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When cardiac 
complaints occur 
in the absence 
of organic findings, 
underlying 
anxiety may be 
one factor 
The influence of anxiety on heart function 
Excessive anxiety is one of a combina--
tion of factors that may trigger a series of 
maladaptive functional reactions which can 
generate further anxiety. Often involved in 
this vicious circle are some cardiac arrhyth--
mias, paroxysmal supraventricular tachycar--
dia and premature systoles. When these 
symptoms resemble those associated with 
actual organic disease, the overanxious 
patient needs reassurance that they have no 
Before prescribing, please consult complete product information, 
a summary of which follows: 
Indications: Relief of anxiety and tension occurring alone or accom-
panying various disease states. 
Contraindications: Patients with known hypersensitivity to the drug. 
Warnings: Caution patients about possible combined effects with alco-
hol and other CNS depressants. As with all CNS-acting drugs, caution patients 
against hazardous occupations requiring complete mental alertness (e.g., oper-
ating machinery, driving). Though physical and psychological dependence 
have rarely been reported on recommended doses, use caution in administer-
ing to addiction-prone individuals or those who might increase dosage; with-
drawal symptoms (including convulsions), following discontinuation of the 
drug and similar to those seen with barbiturates, have been reported. Use of 
any drug in pregnancy, lactation, or in women of childbearing age requires 
that its potential benefits be weighed against its possible hazards. 
Precautions: In the elderly and debilitated, and in children over six, 
limit to smallest effective dosage (initially 10 mg or less per day) to preclude 
ataxia or oversedation, increasing gradually as needed and tolerated. Not rec-
ommended in children under six. Though generally not recommended, if 
combination therapy with other psychotropics seems indicated, carefully 
consider individual pharmacologic effects, particularly in use of potentiating 
drugs such as MAO inhibitors and phenothiazines. Observe usual precautions 
organic basis and that reduction of exces, 
sive anxiety and emotional overreaction 
would be medically beneficial. 
The benefits of antianxiety therapy 
Antianxiety medication, when used to 
complement counseling and reassurance, 
should be both effective and comparatively 
free from undesirable side effects. More than 
13 years of extensive clinical experience has 
demonstrated that Librium ( chlordiazepox, 
ide HCl) fulfills these requirements with a 
high degree of consistency. Because of its 
wide margin of safety, Librium may generally 
be administered for extended periods, at the 
physician's discretion, without diminution 
of effect or need for increase in dosage. (See 
summary of prescribing information.) If 
cardiovascular drugs are necessary, Librium 
is used concomitantly whenever anxiety is a 
clinically significant factor. (See Pre, 
cautions.) Librium should be discontinued 
when anxiety has been reduced to appropri, 
ate levels. 
in presence of impaired renal or hepatic function. Paradoxical reactions 
(e.g., excitement, stimulation and acute rage) have been reported in psychi-
atric patients and hyperactive aggressive children. Employ usual precautions 
in treatment of anxiety states with evidence of impending depression; suicidal 
tendencies may be present and protective measures necessary. Variable effects 
on blood coagulation have been reported very rarely in patients receiving the 
drug and oral anticoagulants; causal relationship has not been established 
clinically. 
Adverse Reactions: Drowsiness, ataxia and confusion may occur, espe-
cially in the elderly and debilitated. These are reversible in most instances by 
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are isolated instances of skin eruptions, edema, minor menstrual irregularities, 
nausea and constipation, extrapyramidal symptoms, increased and decreased 
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function have been reported occasionally, making periodic blood counts and 
liver function tests advisable during protracted therapy. 
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in chronic pain: continued relief without risk of tolerance 
Though Talwin® Tablets can be 
compared to codeine in analgesic 
efficacy, Talwin is not subject to 
narcotic controls. For patients who 
require potent analgesia for prolonged 
periods, Talwin can provide consistent, 
long-range relief, with fewer of the 
consequences you've come to expect 
with narcotic analgesics. 
• Comparable to codeine In analgesic efficacy: one 50 mg. 
Talwin Tablet appears equivalent In analgesic effect to 60 mg. 
(1 gr.) of codeine. Onset of significant analgesia usually 
occurs within 15 to 30 minutes. Analgesia is usually main-
tained for 3 hours or longer. 
• Tolerance not a problem: tolerance to the analgesic effect 
of Talwin Tablets has not been reported, and no significant 
changes in clinical laboratory parameters attributable to the 
drug have been reported. 
• Dependence rarely a problem: during three years of 
wide clinical use, only a few cases of dependence have been 
reported. In prescribing Ta/win for chronic use, the physician 
should take precautions to avoid increases in dose by the 
patient and to prevent the use of the drug in anticipation of 
pain rather than for the relief of pain. (See last page for a 
complete discussion of Warnings under Brief Summary.) 
• Generally well tolerated by most patients: infrequently 
cause decrease in blood pressure or tachycardia; rarely cause 
respiratory depression or urinary retention; seldom cause diar-
rhea or constipation. If dizziness, lightheadedness, nausea or 
vomiting are encountered, these effects may decrease or dis-
appear after the first few doses. (See last page of this advertise- . 
ment for a complete discussion of Adverse Reactions and a Brief 
Summary of other Prescribing Information.) 
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Analgesic for Oral Use-Brief Summary 
Indications: For the relief of moderate to severe pain. 
Contraindication: Talwin should not be administered to patients who 
are hypersensitive to it. 
Warnings: Drug Dependence. There have been instances of psycho-
logical and physical dependence on parenteral Ta/win in patients with 
a history of drug abuse and, rarely, in patients without such a history. 
Abrupt discontinuance following the extended use of parenteral Ta/win 
has resulted in withdrawal symptoms. There have been a few reports 
of dependence and of withdrawal symptoms with orally administered 
Ta/win. Patients with a history of drug dependence should be under 
close supervision while receiving Ta/win orally. 
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pressant effects of Talwin and its potential for elevating cerebrospinal 
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Usage in Pregnancy. Safe use of Talwin during pregnancy (other than 
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should be administered to pregnant patients (other than labor) only 
when, in the judgment of the physician, the potential benefits outweigh 
the possible hazards. Patients receiving Talwin during labor have ex-
perienced no adverse effects other than those that occur with com-
monly used analgesics. Talwin should be used with caution in women 
delivering premature infants. 
Acute CNS Manifestations. Patients receiving therapeutic doses of 
Talwin have experienced, in rare instances, hallucinations (usually 
visual), disorientation, and confusion which have cleared spontaneously 
within a period of hours. The mechanism of this reaction is not known. 
Such patients should be very closely observed and vital signs checked. 
If the drug is reinstituted it should be done wiih caution since the 
acute CNS manifestations may recur. 
Usage in Children. Because clinical experience in children under 12 
years of age is limited, administration of Talwin in this age group is not 
recommended. 
Ambulatory Patients. Since sedation, dizziness, and occasional eu-
phoria have been noted, ambulatory patients should be warned not to 
operate machinery, drive cars, or unnecessarily expose themselves to 
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Precautions: Certain Respiratory Conditions. Although respiratory de-
pres0sion has rarely been reported after oral administration of Talwin, 
the drug should be administered with caution to patients with respira-
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Impaired Renal or Hepatic Function. Decreased metabolism of the 
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Talwin on the sphincter of Oddi, the drug should be used with caution 
in patients about to undergo surgery of the biliary tract. 
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drawal symptoms after receiving Talwin. 
CNS Effect. Caution should be used when Talwin is administered to 
patients prone to seizures; seizures have occurred in a few such 
patients in association with the use of Talwin although no cause and 
effect relationship has been established. 
Adverse Reactions: Reactions reported after oral administration of 
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pation; and rarely abdominal distress, anorexia, diarrhea. CNS effects: 
dizziness, lightheadedness, sedation, euphoria, headache; infrequently 
weakness, disturbed dreams, insomnia, syncope, visual blurring and 
focusing difficulty, hallucinations (see Acute CNS Manifestations under 
WARNINGS); and rarely tremor, irritability, excitement, tinnitus. Auto-
nomic: sweating; infrequently flushing; and rarely chills. Allergic: in-
frequently rash; and rarely urticaria, edema of the face. Cardiovascular: 
infrequently decrease in blood pressure, tachycardia. Other: rarely 
respiratory depression, urinary retention. 
Dosage and Administration: Adults. The usual initial adult dose is 1 tab-
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Duration of Therapy. Patients with chronic pain who have received 
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symptoms even when administration was abruptly discontinued (see 
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Laboratory tests of blood and urine and of liver and kidney function 
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INTRODUCTION 
The 45th Annual McGuire Lecture Series has 
been devoted to the subject of Immunology and the 
Rheumatic Diseases. In this two-day period, 22 
outstanding physicians in the field of immunology 
and rheumatology brought an up-to-date overall 
concept in the field of rheumatic diseases. Subjects 
included not only aspects of pathogenesis but also 
modern laboratory methods in the diagnosis of 
various connective tissue diseases. The remedial 
surgical approaches for prevention of pain and dis-
ability in rheumatoid arthritis were discussed from 
a practical viewpoint. This symposium was spon-
sored in part by the Virginia Chapter of the Ar-
thritis Foundation as well as the Department of Con-
tinuing Education at the Medical College of Virginia. 
Because of the numerous papers submitted, it was 
decided by the editorial board to devote two issues 
of the MCV / Q to this series, which will include 
many of the papers presented at the symposium. 
This year our McGuire Lecturer was Morris 
Ziff, M.D., Ph.D. , Professor of Internal Medicine 
at the University of Texas Southwestern Medical 
School in Dallas . Dr. Ziff is a world-recognized 
authority on immunology and connective tissue 
diseases. He is a past president of the American 
Rheumatism Association, recipient of the Heberden 
Medal awarded by the Heberden Society of London, 
distinguished Alumni Lecturer at the New York 
University and the first Walter Bauer Lecturer at 
the Massachusetts General Hospital. As Dr. Toone 
so aptly remarked in his introduction, "Dr. Ziff 
has the ability to be firm without rancor, to use 
quiet humor to establish a point and above all, 
pre-eminent prestige without a trace element of 
arrogance." The first lecture which he delivered was 
entitled "Immunological Aspects of Rheumatoid 
Arthritis" and the second was "Viruses and the 
Connective Tissue Diseases." 
The latter will be included in the second issue 
of the MCV /Q along with other papers in the 
fields of juvenile rheumatoid arthritis, ankylosing 
spondylitis, infectious arthritis and the more recent 
aspects of antigenic determinants associated with 
ankylosing spondylitis, psoriatic spondylitis and 
Reiter's syndrome. 
ROBERT IRBY, M.D. 
Professor of Medicine 
Department of Medicine 
Medical College of Virginia 
Virginia Commonwealth University 
Modern Immunology: Cells and Molecules* ** 
FRANKLIN MULLINAX, M. D. 
Associate Professor of Medicine, Division of Connective Tissue 
Diseases, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond 
In this presentation I shall discuss 1) some 
historical highlights in the field of immunology; 2) 
the molecules of immunity, pa_rticularly the im-
munoglo bulins; and 3) the cells of immunity, par-
ticularly the immunocytes. This presentation may 
provide a background for subsequent articles. 
· Some Historical Highlights (Tables 1 and 2). 
From its origins, immunology has been closely asso-
ciated with infectious diseases, a bias from which we 
are only now escaping. In the work of early investi-
gators, we can see the clear demonstrations that 
1) immunity is important in prevention of disease; 
2) there are humoral and cellular phases of the 
immune response; and 3) immune reactions can 
themselves produce disease. 
Edward Jenner (1749-1823) and Vaccination. 
Systematic studies by this quiet scholarly country 
physician established that inoculation with cowpox 
pustules produced immunity to smallpox. The prac-
tice of inoculation or variolation had existed in the 
Orient from early times. Material from the vesicle 
or pustule of an active case of smallpox was inocu-
lated into the. skin in order to produce a mild and '· 
immunizing attack of smallpox. The value of this ' 
method was clearly documented in Benjamin Frank-
lin's pamphlet of 1759, "Some account of the 
success of inoculation for the smallpox in England 
and America." Jenner proved that the much more 
innocent inoculation with cowpox pustules was also 
successful. During his studies he also discovered 
that viruses can be attenuated and that an accele-
* Presented by Dr. Mullinax at the 45th Annual McGuire 
Lecture Series, November 8, 1973, at the Medical College 
of Virginia, Richmond. 
**This is publication No. 67 from the Charles W. 
Thomas Arthritis Fund. 
MCV QUARTERLY 10(1): 9-12, 1974 
rated response occurs in previously immunized 
persons. His was the first account of an allergic 
reaction in the skin. 
Louis Pasteur (1822-1895) and the First Heroic 
Phase of Immunology. In his thinking, Louis Pas-
teur was against the temper of his times. Anti-
vitalism was dominant. Liebig and other prominent 
scientists had no use for the animalcules postulated 
to explain the origin of disease and fermentation. 
They were wrong, however, and the germ theory 
rose again with Pasteur's studies of the souring of 
milk. His work followed a natural path from studies 
of crystals to studies of diseases of wirte and silk-
worms, to studies of diseases of man, culminating 
in immunization and prevention of disease. The 
studies of chicken cholera revealed that the microbe 
that kills is the one that immunizes and that the 
microbe may be attenuated. They suggested to him 
the possibility of attacking diseases of man. Finally, 
the renowned studies of rabies led to inoculation 
of young Joseph Meister on July 6, 1885 with the 
first and least virulent of his rabies vaccines. Joseph 
survived the series of injections and became the 
gatekeeper at the Pasteur Institute. 
Pasteur's experiments on immunization were 
followed by a great outpouring of studies of immu-
nology with concurrent deveiopment of biologic and 
chemical concepts of immunity. On the biological 
side, Eli Metchnikoff, the wild Russian, migrated 
to Pasteur's laboratory and championed the non-
specific and the cellular aspects of immunity. While 
looking through his microscope, Metchnikoff saw 
cells engulfing particles and became the primary 
discoverer of phagocytosis as a defense mechanism. 
Koch, also at the Pasteur Institute, showed that 
whereas the first intradermal injection of tubercle 
9 
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TABLE 1 
JMMUNOBIOLOGY 
May 14, 1796 Edward Jenner established vaccination. 
July 6, 1885 Louis Pasteur injected attenuated rabies 
virus into Joseph Meister. 
1882 Eli Metchnikoff and phagocytosis. 
To 1905 Bordet,Arthus, vonPirquet, Schick, Ehrlich. 
1953 Owen, Medawar and Burnet. Immunologic 
tolerance. 
bacilli evoked no response in guinea pigs, the sec-
ond injection led to an inflammatory reaction, thus 
initiating the concept of delayed hypersensitivity 
or cellular immunity. 
The Pasteur Institute was also involved in chem-
ical studies of immunity. After Pasteur's work on 
bacteria as the cause of diseases of wine, beer, and 
later, of man, attention turned to diphtheria. Roux 
expected that this devastating disease would be 
characterized by massive bacterial proliferation; but 
only a few bacilli could be isolated from the iocal 
lesion. Something else must be responsible for the 
toxicity of diphtheria. This line of investigation led 
to the isolation of bacterial toxins, the preparation 
of antitoxins, identification of the antitoxins as serum 
TABLE 2 
IMMUNOCHEMISTRY 
October 30, 1845 William Macintyre examined the urine 
of his patient, Mr. Macbee, who had 
myelomatosis. 
1890 
1900 
1920 
1948 
1%0's 
Roux and Behring identified toxiris and 
antitoxins. 
Landsteiner described blood group an-
tigens and antibodies. 
Beginnings of quantitative immuno-
chemistry with Heidelberger, and later, 
Kabat and Marrack. 
Hargraves described the LE cell. 
Fundamental discoveries of antibody 
structure: Putnam, Porter, Edelman, 
Hood, Dreyer. 
proteins, prophylactic use of antitoxin-containing 
sera, and description of serum sickness. This phase 
of research extended through 1905 with the publi-
cation of Serum Sickness by von Pirquet and Schick. 
Forgetting many other important contributions, we 
may tum to 1953 and the development by Owen, 
Medawar, and Burnet of the concept of immuno-
logic tolerance, another landmark in the biology of 
immunity. 
The Chemistry of Immunity. On October 30, 
1845 a practicing physician, William Macintyre, 
examined the urine of his patient, Mr. Macbee, 
who had the disease now known as multiple mye-
loma. The peculiar reactivity of . his urine-a pre-
cipitate formed on warming and dissolved with boil-
ing--led Dr. Macintyre to consult with Dr. Henry 
Bence Jones. More than a hundred years later, 
studies of the Bence Jones proteins ushered in a 
second heroic phase of immunology. Bence Jones 
proteins and serum monoclonal proteins have proved 
to be a Rosetta stone of immunology. 
In 1900 Karl Landsteiner discovered blood 
group antigens and their corresponding antibodies. 
His chemical studies, particularly with low molecular 
weight haptens, set the stage for quantitative im-
munochemistry, developed by Heidelberger and 
Kabat, and by Marrack, from the 1920's through 
the 1950's. The discovery of the LE cell by Har-
graves in 1948 was important because it led to 
detailed studies of the chemical basis of apparent 
autoimmune reactions. Early in the 1960's the work 
of Edelman, Porter, Putnam, and others gave the 
central focus of immunology on the now familiar 
four-chain structure of an antibody monomer. 
The Immunoglobulins. It is fortunate that the 
simple technique of paper or cellulose acetate elec-
trophoresis provides a rather complete separation 
TABLE 3 
THE IMMUNOGLOBULINS 
lgG-The main antibody class. 
lgA-Antibody, especially in secre!ions. 
IgM-Macroglobulins. 
JgD-? 
lgE-Skin sensitizing antibody. 
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of the antibodies. Most antibodies are in the y-
globulin fraction and most y-globulins are antibodies. 
More sophisticated techniques, particularly immuno-
electrophoresis, reveal that some antibodies are in 
other electrophoretic fractions and that there are 
at least five classes of antibodies. These are the 
immunoglobulins: IgG, lgA, IgM, lgD, and lgE 
(Table 3). IgG is the main circulating immuno-
globulin; IgA is prominent in secretions (tears, 
saliva); lgM is generally a pentameric molecule, 
restricted to the intravascular space and particu-
larly effective biologically; IgD is a minor com-
ponent of uncertain function; and lgE is present in 
trace amounts but is extremely important because 
it mediates immediate ( anaphylactic) hypersensi-
tivity. 
A diagrammatic representation (Fig. 1) of the 
IgG molecule reveals that it has four chains-two 
light chains and two heavy chains. The light chains 
(Bence Jones proteins) are often produced in ex-
cess by plasma cells. Large amounts of these proteins 
are excreted by many patients with myelomatosis. 
Variations in amino acid sequences in the first part 
of the light and heavy chains provide variations in 
antibody specificity, that is, antibody diversity. Fur-
ther structural studies reveal that the light chains 
have two and the heavy chains have four disulfide 
domains, homologous parts of the molecule which 
rotate almost independently. Another way to ex-
amine the molecule is literally by looking at it. 
High-resolution electron micrographs reveal the 
lgG molecules to be Y-shaped with the two antigen 
binding sites on the forks. lgM molecules have five 
monomer Y's around a central core. 
{Light chain (Bence Jones protein) 
s 
Heavy chain 
s f 
s 
s 
s 
Antigen binding site 
Fig. I-Diagrammatic representation of an lgG molecule. 
Fig. 2-Electron micrograph of a plasma cell from a human 
kidney graft removed because of impending rejection. Note 
the prominent endoplasmic reticulum. (Courtesy of Dr. 
W. J. S. Still, Medical College of Virginia). 
These immunoglobulins are the mediators of 
humoral immunity and are produced by cells of 
the plasma cell series. These secretory cells (Fig. 2) 
have an elaborate endoplasmic reticulum which 
contains the organelles concerned with synthesis 
and secretion of plasma proteins. 
Cellular Immunity. A different group of cells, 
activated lymphocytes, mediate cellular immune re-
actions. Such an activated lymphocyte is see·n in 
figure 3. Upon antigenic stimulation, lymphocytes 
mediating cellular immune reactions enlarge, divide, 
and provide mediators, lymphokines, which incite 
local inflammatory reactions. Cellular immunity is 
largely responsible for immunity against intracellular 
parasites, contact drug allergy, graft rejection, and 
tumor rejection. A typical reaction of cellular im-
munity is the reaction of delayed hypersensitivity, 
such as the tuberculin reaction. 
Observations on patients with immunodeficiency 
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Fig. 3-Electron micrograph of a transformed lymphocyte 
in the splenic white pulp of a lethally x-irradiated mouse 
36 hours after injection of rat small lymphocytes. Note the 
absence of endoplasmic reticulum. This rat lymphocyte 
became transformed after contact with immunologically 
foreign mouse tissue. It is now prepared to provide a line 
of cells mediating the graft-versus-host response. (Courtesy 
of Dr. J. L. Gowans, Oxford University, and publishers, 
S. Karger, Basel/New York).1 
diseases and experiments in animals have given 
rise to the concept of two different systems that 
mediate humoral and cellular immunity (Fig. 4). 
According to this view, stem cells from the bone 
marrow migrate to breeding sites for the cells of 
the two types of immunity. In the chicken, plasma 
1 Reprinted by permission from Gowans JL, McGregor 
DD : The immunological activities of lymphocytes. Progress 
in Allergy 9: 1, 1965. 
cell precursors (B cells) are produced in the bursa 
of Fabricius, an organ near the cloaca. In man, the 
- corresponding tissues are not clearly identified. The 
marrow itself or gut-associated lymphoid tissue may 
be involved. The second breeder site is the thymus. 
It provides T lymphocytes and cellular immunity. 
Interrelations of T and B cells are complicated and 
important, as some of the following presentations 
will indicate. 
In this brief overview, I have presented some 
historical highlights of chemical and biologic ap-
proaches to immunology. The chemical approaches 
lead to our current detailed picture of immuno-
globulin structure. The biologic studies lead to the 
concept of a two-component system, B and T cells, 
mediating humoral and cellular immunity. These 
chemical and biologic findings provide a framework 
for analyzing not only basic immunology but also 
clinical diseases. For completion, I should briefly 
mention the scavenger macrophages-probably im-
portant in antigen processing; the complement sys-
tem-important in amplifying the effects of an 
immune response; the kinins and other molecules 
of inflammation; and the polymorphonuclear leuko-
cytes and other apparently nonspecific defenders. 
The Immunologic Mosaic. The outlines of mod-
ern immunology are now discernible. The resultant 
picture is like a mosaic rather than a photograph. We 
are now at the exciting point where the form is 
emerging. 
BONE MARROW 
! 
Stem4 Cells 
~ ~URSA-LIK~ TISSUES! 
Thymic (T) tymphocytes 
i 
Bursa! (B) Lymphocytes 
Lymph nodes, spleen, Peyer's patches 
J, + Antig.en (Ag) 
Ag-specific transformed lymphocytes 
"'lJ .!~ 
Proliferation of thymic- dependent and 
antigen-sper '.fic lymphocytes in para-
cortica l areas -+Ag- specific cellular 
immunity (delayed hype rsensitivity) 
(cell-bound antibody) and immunologic 
memory . 
Proliferation of bursal-dependent 
and antigen specific lymphocytes 
in germinal centers and develop-
ment of plasma cells - Ag-specific 
humeral immunity (circulating antibodies) 
(lg's) and im munologic memory . 
Fig. 4-Bone marrow - thymus - bursa interrelations. The 
bursa-like tissues in man may be either the bone marrow 
itself or certain gut-associated lymphoid tissues (GALT). 
Recent Advances in Synovial Fluid Analysis* 
DUNCAN S. OWEN, JR., M. D., F. A. C. P. 
Associate Professor of Medicine, Division of Connective Tissue 
Diseases, Medical College of Virginia, Health Sciences Division of 
Virginia Commonwealth University, Richmond 
Synovial fluid analysis is a frequently ignored 
examination except in suspected cases of septic con-
ditions. It has been shown that it is an extremely 
valuable procedure in making rapid and accurate 
diagnoses in many types of joint diseases. 
Table 1 illustrates the findings in ten separate 
joint states. The gross appearance, "wet-prep" 
microscopic examination, leukocyte count and sugar 
content are procedures that are extremely important 
and can be performed with a paucity of equipment. 
We have not found the mucin-clot test or protein 
content to be very helpful. Of course, if infection 
is a possibility, Gram's stain and appropriate cultures 
should be instituted. It should be remembered, how-
ever, that only 25-30% of the cases of gonococcal 
arthritis will be associated with a positive Gram's 
stain or culture. The culture yield may possibly 
improve with the increasing use of Thayer-Martin 
media. The anticoagulant should be either heparin 
or EDT A instead of oxalate because the examiner 
may confuse oxalate crystals with urate or pyro-
phosphate crystals. 
Cell Counting. The white blood cell count is of 
particular importance in suspected septic conditions. 
Methods have been outlined in detail in an excel-
lent book by Ropes and Bauer. The fluid should 
.be collected in an anticoagulant tube. The diluent 
should be··physiologic saline because acetic acid will 
cause precipitation of mucin and make an accurate 
count practically impossible. The addition of 
methylene blue to the diluent will help differentiate 
the cell types. If the fluid is hemorrhagic, a hypo-
* Presented by Dr. Owen at the 45th Annual McGuire 
Lecture Series, November 8, 1973, at the Medical College 
of Virginia, Richmond. 
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tonic diluent of 0.3% sodium chloride can be tried 
which theoretically will disrupt the red blood cells 
but not the nucleated cells. 
A differential white count using Wright's stain 
is performed in the same manner as a peripheral 
blood smear. If the total white blood count in the 
synovial fluid is less than 5,000/mm3 , it is best to 
centrifuge the fluid at 2,000-3,000 rpm for ten 
minutes. The supernatant is then removed arid 
physiologic saline added to the sediment until. the 
original volume is obtained. The solution should 
then be recentrifuged which will remove most of 
the mucin. The sediment can then be easily smeared 
on a slide, air dried, and stained. In cases of sys-
temic lupus erythematosus (SLE), the .LE cell may 
be seen. 
Glucose. The glucose value of normal synovial 
fluid usually parallels that of serum. The results are 
of greater value if the patient has been fasting for 
about six hours. It is even possible for normal 
synovial fluid sugar to be higher than that of the 
serum for several hours postprandially. 
In any suspected septic joint condition, a glu-
cose determination should always be performed. We 
have found the glucose levels to be low in almost all 
cases of septic arthritis observed at the Medical 
College of Virginia during the past seven years. It 
is important to have the glucose level determined 
immediately after aspiration. Because of the glu-
colytic action of white cells, falsely low levels may 
be observed in cases of rheumatoid arthritis and 
gout, for example, if the white cell count of the 
fluid is high and the fluid is not tested for one or 
more hours. The falsely low sugar level can also 
be prevented by placing the fluid to be tested in a 
sodium fluoride tube. A synovial glucose of 50 mg % 
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TABLE 1 
SYNOVIANAL YSIS 
Mucin Leukocytes 
Disease Appearance Clot Viscosity per mm3 
Normal Clear, Good High <200 
amber <25% polys 
Gouty Milky or Poor Low 15,000+ 
Arthritis yellow 70% polys 
Pseudogout Turbid, Fair to Fair or 25,000± 
amber, or Poor Low 90% polys± 
yellow 
Rheumatoid Turbid, Poor Low 15,000+ 
Arthritis amber to 70% polys 
light green 
Septic Very turbid, Poor Low 70,000± 
Arthritis gray 90% + polys 
Tuberculous Turbid, Poor Low 30,000± 
.(\rthritis amber, or 60%± polys 
yellow 
Osteoarthritis Clear, Good High 1000± 
amber 10% polys 
Acute Bloody or Good High <2000 
Traumatic turbid <25% polys 
Arthritis 
Systemic Slightly Good High 3000± 
Lupus turbid, <10% polys 
Erythematosus amber 
Rheumatic Slightly Good Fair 15,000 
Fever turbid, to Low 50% polys 
amber 
less than fasting serum should be considered as 
strongly indicating an infectious process until 'proved 
otherwise. 
"Wet Drop" Preparation Studies. The micro-
scopic examination of a drop of fresh or anticoagu-
lated synovial fluid may yield diagnostic information, 
especially in cases of crystal deposition diseases 
(gout and pseudogout). This examination is per-
formed by placing a small drop of synovial fluid 
on a glass slide, covering with a cover slip and 
sealing the edges with clear fingernail polish. Only 
a small drop is used to prevent individual cells from 
Sugar: serum-
synovial difference 
(mg/lOOml) Crystals Comment 
<10 None 
10± Sodium Strongly negative bire-
urate fringent intra- and extra-
cellular urate crystals. 
10± Calcium Few-to-many weakly 
pyrophosphate positive intra- and extra-
cellular calcium pyro-
phosphate crystals. 
25 Occasional WBC inclusions fre-
cholesterol quently present. 
Rheumatoid factor 
usually present. 
70 None Culture positive in only 
20-30% of GC cases. 
so+ None Biopsy frequently 
helpful. 
<10 None Cartilage fibrils may 
be present. 
<10 None Occasional cartilage 
fibril. Many RBC's. 
10± None Examine for LE 
cells. 
10± None Occasional WBC 
inclusion 
moving across the field of view. Sealing the slide 
prevents the formation of artifacts while drying and 
will preserve the specimen for one or more hours. 
The synovial fluid findings in the crystal deposi-
tion diseases, gout (monosodium urate crystal depo-
sition disease) and pseudogout (calcium pyrophos-
phate dihydrate crystal deposition disease), were 
described in the early 1960's. The discovery and 
identification of these crystals in synovial fluid, 
using the compensated polarizing microscope, led 
to great enthusiasm in making rapid and accurate 
diagnoses of crystal-induced synovitis. Unfortunately, 
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the compensated polarizing microscope is an ex-
pensive piece of equipment, which is not readily 
available in the office of most physicians and it is 
infrequently found in general hospitals. 
Simple Polarization. A simple polarizing micro-
scope can be made from an ordinary microscope 
by inserting a polarizing filter below the condenser, 
usually on top of the light source (the polarizer), 
and using one filter above the objective, usually in 
the barrel or above the eye piece (the analyzer). 
The polarizer is then rotated until the darkest field 
possible is obtained. The monosodium urate (MSU) 
crystals usually appear as bright needles against 
this black background. The calcium pyrophosphate 
dihydrate ( CPPD) crystals usually appear in bright 
monoclinic, triclinic, rectangular or rhomboid forms, 
and may be quite difficult to differentiate from 
MSU crystals in synovial fluid . Figure 1 illustrates 
the placement of simple plastic polarizing filters 
in a laboratory microscope. 
Compensated Polarization. The compensated 
polarizing microscope utilizes a first-order red filter, 
the compensator, which is inserted between the 
objective and the analyzer. The compensator retards 
red light and the polarized background becomes 
red instead of black. The axis of the line of slow 
vibration of the compensator is then defined. The 
MSU and CPPD crystals will be either yellow or 
blue, depending upon their respective positions to 
this axis. The MSU crystal is brightly yellow when 
parallel to the axis and indicates that it is strongly 
negatively birefringent. The CPPD crystal is faintly 
blue when in this position, indicating weakly posi-
tive birefringence. 
On occasion, both MSU and CPPD crystals 
are noted in the same fluid indicating coexisting 
disease. Previously injected adrenocorticosteroids, 
oxalate anticoagulant, cholesterol crystals, and 
scratches on the slide or coverslip should not be 
confused with either MSU or CPPD crystals. 
New and Simple Technique. We have found a 
very adequate substitute for the first-order red filter 
which can be used with an ordinary light micro-
scope which has been adapted with simple polarizing 
filters. One needs only a clean microscopic glass 
slide and simple transparent cellophane tape. One 
piece of the cellophane tape is carefully applied 
to the top side of the slide and then another piece 
of tape is applied over this. Wide tape is preferable 
but two pieces of narrow tape carefully applied 
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Fig. I-Illustration of simple plastic polarizing filters in 
barrel of microscope (analyzer) and above light source 
(polarizer) . 
beside two other pieces is satisfactory. The micro-
scope is then adapted for simple polarizing micro-
scopy as previously described. (One may first wish 
to focus on the material to be examined.) The 
cellophane-taped slide is then placed over the 
polarizer and carefully rotated until the background 
is quite red. We have discovered that the long axis 
of the taped slide substitutes amazingly well for 
the axis of slow vibration of the first-order red 
compensator. The examiner can theh mentally pro-
ject the axis of the taped slide on the stage. Figure 2 
illustrates the celiophane-taped slide on top of the 
polarizer. With the stage arranged to permit free 
movement of the "wet-prep" slide, the examiner 
can then rotate the "wet-prep" slide and define 
whether the observed crystals are negatively or 
positively birefringent. 
It should be emphasized that cellophane is 
closely controlled for thickness in its manufacturing 
process but not for its r~fractive index. Therefore, 
there may be a different retardation with each supply 
of cellophane tape. We have tested numerous 
batches of cellophane tape. Approximately 50% 
will give the red background and the other 50% 
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a blue background. The interested examiner may 
have to purchase a few rolls of tape until a satis-
factory one is found. 
The improvised compensated polarizing micro-
scope techniques described above have been a 
tremendous help in making a rapid and accurate 
diagnosis of crystal-induced synovitis. Faculty, 
housestaff, and students are encouraged to carry 
polarizing filters and a cellophane-taped microscope 
slide with them. A great deal of enthusiasm has been 
expressed. For the first time, individuals are really 
learning the true meaning of the planes of bire-
fringence. In the past, many individuals memorized, 
in preparation for written examination, which crys-
tals were negatively or positively birefringent. It is 
hoped that others will discover these techniques 
to be helpful to them. Examiners will be greatly 
helped in establishing theii: own personal techniques 
by smearing some MSU crystals from a tophus on 
a clean microscopic slide. They can then experiment 
with the filters until the simple maneuvers are 
mastered. 
Ragocytes (RA cells, inclusion body cells, 
raisin seed cells) in syriovial fluid of patients with 
rheumatoid arthritis were originally described by 
Dr. Joseph Hollander and associates. These cells 
-a 
POLARIZER 
Fig. 2-Illustration of "cellophane tape compensator" above 
the polarizer. 
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are leukocytes containing inclusion bodies. They 
appear as dark granules under regular light micro-
scopy at high dry magnification and as clear vacuo~ 
lated areas with phase microscopy. It was assumed 
that these bodies were phagocytosed rheumatoid 
factor and they were noted in from 5-95% of the 
total leukocyte population of rheumatoid synovial 
fluid . It was believed that phagocytosis of rheuma-
toid factor played a role in the pathogenesis of 
rheumatoid arthritis in a similar fashion to the 
phagocytosis of sodium utate crystals in the patho-
genesis of gouty arthritis. This concept was supported 
with the production of acute synovitis by the . in-
jection of autologous yG-globulin into inactive joints 
of patients with rheumatoid arthritis. Subsequent 
studies have shown that the findings of these leuko-
cyte inclusions are not specific for rheumatoid ar-
thritis. They may be found in other types of inflam-
matory joint disease and may be scavengers which 
have phagocytosed products of inflammation includ-
ing y-globulins. 
Osteoarthritis fluid may reveal a few-to-many 
cartilage fibrils and fragments. These may also be 
seen in cases of pseudogout. 
Cholesterol crystals are noted rarely in the 
fluid of cases of chronic rheumatoid arthritis. These 
crystals are large, rhomboid, have punched-out 
corners and are birefringent. 
An inexperienced examiner may confuse pre-
viously injected corticosteroid ester crystals with 
urate or pyrophosphate crystals. The steroid crystals 
may be phagocytosed by white cells and apparently 
can precipitate a "postinjection flare" of the in-
jected joint. The crystals are usually negatively 
birefringent. 
Reiter's syndrome synovial fluid has been re-
ported to show large mononuclear cells containing 
many vacuoles. Some of these cells appear to con-
tain polymorphonuclear cells. The specificity of this 
is unclear. 
Table 2 illustrates the complement (C') levels 
in various disease entities. It is most helpful, how-
ever, to know the normal values and type of com-
plement determination for each laboratory. For 
example, if total complement is determined on a 
viscous synovial fluid and if a diffusion technique 
is used, poor diffusion may occur due to viscosity 
and erroneously low level results. 
Summary and Conclusions. Examination of syno-
vial fluid is a most helpful test for making a 
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TABLE 2 
COMPLEMENT 
Rheumatoid arthritis 
Systemic lupus erythematosus 
Reiter's 
Septic 
Crystal disease 
Spondylitis & psoriasis 
Serum 
N (rarely l) 
l 
N 
N (occ. i) 
N 
N 
Synovial Fluid 
l 
l 
ii 
t 
Nori 
Nori 
definitive diagnosis of one of the various types of 
arthritis, especially gout, pseudogout and septic 
arthritis. Unfortunately, it is one of the most fre-
quently ignored tests. It should be remembered that 
only a few drops of fluid are needed for a "wet drop" 
examination for crystals, ragocytes, Gram's stain and 
a Wright's stain. 
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Surgery in Rheumatoid Arthritis: General Indications 
and Philosophic Considerations* 
R. S. BRYAN, M. D. 
Assistant Professor, Orthopedic Surgery, Mayo Medical School, 
University of Minnesota; Consultant, Mayo Clinic, Rochester 
An orthopedic surgeon once referred to gen-
eral surgeons as "residual surgeons"; and in rheuma-
toid arthritis, orthopedic surgeons might be referred 
to as surgeons of the residuum because we are called 
only after all of the medical treatments. We would 
like to be called earlier because we do have some-
thing to offer many patients. 
One of the dramatic developments of recent 
years in rheumatoid arthritis is the rehabilitation 
potential that is realized in total joint replacement. 
It is miraculous when a patient who has become 
bedfast despite good ·medical management is ren-
dered ambulatory within six weeks by the replace-
ment of two or three lower extremity joints. This 
is not possible, however, in every patient; and the 
abyss of total disaster and even death lurks behind 
every improperly chosen and orchestrated surgical 
sequence. 
Successful results of surgery in the arthritic 
depend as much on a wise choice of patient and 
operation as on the skillful performance of the 
surgery. The most important consideration in choos-
ing the patient is that' he or she is willing to have 
the operation. Operating on unwilling patients often 
leads to lawsuits and generally gives rise to dis-
comfort for both patient and surgeon. Willing, how-
ever, means not only that the patient is willing to 
have surgery, but also that the patient understands 
realistically what you are attempting to achieve 
* Presented by Dr. Bryan at the 45th Annual McGuire 
Lecture Series, November 8, 1973, at the Medical College 
of Virginia, Richmond. 
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and is willing to cooperate fully in order to attain 
the desired result. 
Motivation is slightly different but is ancillary; 
the patient must want to have the operation, not the 
relatives. If the relatives push the patient into the 
room and say, '"Mother wants to have her knees 
operated on," beware. That patient may be per-
fectly happy to sit in a wheelchair and may be 
bitterly resentful after surgery. I mistakenly oper-
ated on such a patient, replacing both knee joints 
and stretching out contractures of 60 degrees. After 
she went home, she took off her braces and allowed 
the contractures to recur because "it was too much 
bother to wear them." I achieved nothing because 
I chose the wrong patient for surgery. 
The second facet of motivation is the willing-
ness to continue good medical management. One 
of my patients had been taking the "Mexican pill" 
and was Cushingoid with destroyed knee joints and 
osteoporotic bones. We replaced both knee joints 
and reduced her steroid doses to a reasonable li;:vel. 
She returned after one year with her knees doing 
well but had resumed large doses of steroids because 
the other joints limited her activities. We achieved 
nothing in that patient since our treatment merely 
permitted her to abuse other joints, and we were 
unable to make her understand and accept her 
disease and its proper management. 
There must exist in the properly chosen patient 
a need for surgery. If there is a mechanical method 
that will suffice by means other than surgery, such 
as injection, splinting, or physical therapy, that 
method should be chosen. 
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Fig. 1-This is a 55-year-old man with rheumatoid ar-
thritis. Note the destruction of bone from the arthritis. 
There are also certain basic requirements in 
the form of muscles, ligaments, and bone structure 
that pertain to each surgical procedure and vary 
from joint to joint. In a Walldius total knee arthro-
plasty, for example, you must have a good quadri-
ceps but do not need ligaments, while in other types 
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Fig. 2-Photograph taken at surgery showing the pros-
theses in place. The high density polyethylene bushing is 
seen separating the metal portions of the hinge. 
of knee replacement, ligament stability is more 
important. 
In rheumatoid arthritis, initially, synovitis oc-
curs with little mechanical damage to the joints; 
but as the disease progresses, structural changes 
Fig. 3 A, B- The x-rays show that the axis of the hinge is in line with the anterior surface of the humerus in the correct 
position . 
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Fig. 4 A, B-These two photographs show the range of motion achieved at three weeks after surgery. 
occur that would cause progressive deterioration, 
even if the arthritis were miraculously cured. Syno-
vectomy at that late stage accomplishes little. The 
difficulty is. in knowing when the mechanical damage 
is severe enough to preclude synovectomy. Cer-
tainly, when erosion and surface irregularities ap-
pear, it is more reasonable to suggest arthroplasty. 
When still more destruction has occurred and gross 
instability ensues, the choice evolves to a hinged 
or unhinged total knee arthroplasty or arthrodesis. 
At each stage in the disease-just as in the medical 
management, the least lethal medication possible 
is used-in surgery, the least lethal operation is 
chosen. 
One of the bold new experiments involves the 
replacement of the elbow joint. Figure 1 shows a 
roentgenogram of a rheumatoid elbow with severe 
destruction, somewhat resembling the old fascia! 
arthroplasties. Figures 2 and 3 show the Coonrad 
hinge. This has a polyethylene bushing through 
which the cross pin connects the two parts of the 
hinge. The stems are cemented to the bone in the 
humerus and ulna. The pin rotates and so do the 
bushings, giving a wide weight bearing area. Figure 
4 shows the patient three weeks after surgery dem-
onstrating his range of motion. 
In summary, orthopedic surgery has much to 
offer the rheumatoid patient, particularly if the 
proper patient is chosen at the proper time. The 
advent of the total joint replacements, now in its 
infancy, gives renewed hope for the salvage of many 
derelicts and for the prevention of the severe dis-
abilities and deformities which were all too frequent 
in the past. 
Surgical Treatment of the Upper Extremity 
in Rheumatoid Arthritis* 
CHARLES L. McDOWELL, M. D. 
Assistant Clinical Professor, Orthopedic Surgery, Medical College of 
Virginia, Health Sciences Division of Virginia Commonwealth 
University, Richmond 
All surgical procedures designed to preserve 
or improve function in the extremities, whether in 
rheumatoid arthritis or not, must consider the func-
tional emphasis of the upper extremity as compared 
to the lower extremity. The upper extremity has, 
as its primary goal, mobility and prehension, whereas 
in the lower extremity, stability is the most im-
portant goal, mobility the next in order of im-
portance, and prehension the least important. For 
example, the feet fulfill a need for stability with 
very little requirement for prehension, but the hand 
is more an instrument for prehension and there 
is less need to consider stability. 
I have divided surgery in the upper extremity 
of the rheumatoid patient into the surgery of pre-
vention and the surgery of repair-that is, those 
procedures designed to prevent the loss of function 
and those designed to restore some measure of 
function. 
Surgery of Prevention. Synovectomy. One might 
include synovectomy under the ·surgery of preven-
tion. The question of whether synovectomy is worth-
while as a possible means of controlling the pro-
gression of rheumatoid disease in any particular 
joint is not appropriate to this discussion. My per-
sonal view is that synovectomy alone has not ade-
quately been shown to favorably alter the course 
of rheumatoid arthritis in the involved joint, al-
though there is definitely a place for synovectomy 
* Presented by Dr. McDowell at the 45th Annual Mc-
Guire Lecture Series, November 8, 1973, at the Medical 
College of Virginia, Richmond. 
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whenever synovial tissue itself interferes with func-
tion or when it is causing intractable pain. Further, 
synovectomy done in association with certain 
anatomic adjustments is an essential element in the 
operative procedure. An example of such a situation 
is illustrated by the patient who has monarticular 
synovitis of a metacarpal phalangeal joint with 
severe pain and limitation of motion and who has 
not responded to the usual conservative methods 
applied over a reasonable period of time. In such 
an instance there is a reasonable chance of attain-
ing at least some pain relief if not some improve-
ment in the range of motion of that joint. 
Anatomic Adjustments. These are procedures 
which are often done in association with synovec-
tomy to prevent further progression of destructive 
processes that we know will cause a functional loss 
to the patient if some surgical adjustment is not 
made. Radial-head excision, along with synovec-
tomy of the elbow joint, may preserve pronation 
and supination at the elbow and perhaps even ftexion 
and extension at the elbow longer than it would 
have been preserved using conservative treatment 
alone. The procedure is also helpful in relieving 
pain. Radial-head excision is ordinarily not con-
sidered as a possibility until there is x-ray evidence 
of advanced destructive changes and clin_ical evi-
dence of persistent pain and reduction in the range 
of motion. 
When the patient has tenosynovitis on the ex-
tensor surface of his wrist and hand, there is a 
threat of possible destruction of extensor tendons 
with consequent severe loss of function. A synovec-
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tomy is in order because the synovial tissue seems 
to cause destruction of the tendons by ingrowth into 
the substance of the tendon; indirectly, there is 
damage by competition with the blood supply and 
also by compression underneath the extensor 
retinaculum which also interferes with the blood 
supply. At the same time that the synovectomy is 
done, the extensor retinaculum is removed, so that 
if synovitis recurs the tendons will not be exposed 
to compression and consequent loss of blood supply. 
Usually the retinaculum itself is preserved but re-
routed beneath the extensor tendons and sutured 
down to the capsule of the wrist joint. This collagen 
graft helps to stabilize the wrist joint itself, so that 
a tissue which was in a potentially destructive posi-
tion before surgery is converted to an assistant 
which may help to stabilize the wrist joint. 
When synovitis in the flexor canal, which con-
tains the long flexor tendons and the median nerve, 
increases the pressure within the volar canal, the 
patient experiences decreased function of the median 
nerve distal to the wrist. There are signs and symp-
toms of carpal tunnel syndrome. If this condition 
is allowed to progress the patient may ultimately 
develop a complete nonfunction of the median 
nerve and the flexor tendons may rupture; the 
mechanism would be the same as that described 
for extensor tendons under the extensor retinaculum. 
Therefore, a release of the volar carpal ligament 
combined with synovectomy will preserve irreplace-
able function of the median nerve and probably 
prevent rupture of the flexor tendons. 
Frequently, synovitis occurs in the flexor ten-
don sheaths in the finger. When it progresses to the 
point where the flexor tendons are unable to glide 
through the pulleys, a situation described as "trigger 
finger" exists. This painful locking of the flexor 
tendons cannot be treated by a simple division of 
the pulleys because severe functional loss is a con-
sequence of division of the pulleys. In this instance 
a complete synovectomy of the flexor tendons in the 
fingers will allow them to become flexible again. 
The Surgery of Repair. Repair or Grafting of 
Ruptured Tendons. As pointed out earlier, the sur-
gery of repair is indicated when anatomic equipment 
has already been destroyed by the rheumatoid 
process and some kind of reconstruction or substitu-
tion should be considered. Some examples include 
the repair or grafting of ruptured tendons. Rupture 
of tendons can occur on the extensor surface of the 
wrist or in the flexor canal or in the digits as a result 
of synovitis as described earlier. Another frequent 
cause of tendon rupture is dorsal dislocation of the 
head of the ulna with sharp bone edges which 
physically abrade the extensor tendons. The repair 
is accomplished by placing a tendon graft between 
the muscle and the distal stump of the tendon and 
by removal of the distal ulna. Other substitution 
procedures include such things as tendon transfers 
to replace ruptured tendons or to replace a specific 
function when there is an imbalance problem caused 
by contractures or tendon rupture. 
Release of "Stuck" Tendons. Another example 
of surgery of, repair is seen in patients who have 
ignored the destructive process or were unaware 
of the destructive process to the point where the 
tendons have stuck together or to surrounding tis-
sues. Consequently, tendon gliding is prevented and 
there is no function in the digit. A reconstruction 
here requires removal of adhesions to allow the 
tendons to glide once again. 
Arthrodesis of Small Joints. The small joints 
in the hand are exposed to the ravages of rheuma-
toid arthritis and osteoarthritis follows directly in 
its footsteps resulting in severe pain and instability. 
Fortunately, some joints do not require motion to 
be useful; therefore, an arthrodesis of some small 
joints which relieves pain and provides stability can 
be a definitive and helpful operation. Arthrodesis 
of the thumb metacarpal phalangeal joint and ar-
throdesis of the wrist are the most commonly per-
formed fusions in patients with rheumatoid arthritis. 
Selective Excision of Rheumatoid Nodules. We 
are all aware of the fact that rheumatoid nodules 
have a high recurrence rate after excision; however, 
nodules may appear in areas where they can cause 
much pain and interfere with function of a hand 
out of proportion to their usually benign nature 
and surgical excision is indicated. 
Resection Arthroplasty of Small Joints. In the 
last thirty years or more, surgeons have been at-
tempting to provide motion and a reduction in pain 
in the small joints of the hand by performing an 
arthroplasty where arthrodesis was not a reasonable 
alternative. We attempted to produce a type of 
pseudojoint by removing a portion of the old de-
stroyed joint and substituting some type of soft 
tissue, such as fascia or tendon, for articular carti-
lage. Such soft tissue arthroplasties have helped to 
reduce pain in the involved joints and have helped 
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to increase the range of motion in the involved 
joints; however, the soft tissue arthroplasties have 
fallen far short of normal function. The soft tissue 
arthroplasties do not hold up over a long period 
of time because the interposed soft tissue tends to 
disappear with time allowing the bone ends to come 
back together and pain is a result. 
Replacement Arthroplasty of Small Joints. 
Presently, soft tissue arthroplasties are being aug-
mented by the use of a spacer between the two 
bone ends to prevent the two bone ends from mi-
grating back together. The spacers which are in-
serted also have a certain amount of inherent rigidity 
which improves the stabilizing characteristics of the 
arthroplasty. We are using Silastic® spacers or 
prostheses of which there are now three popular 
types: Swanson, Niebauer, and Calnan-Nickel (the 
Swanson type is illustrated). Experience has shown 
that the implant type of arthroplasty can greatly 
improve the average range of motion following sur-
gery and can also maintain pain reduction for many 
years. Stability is improved over the pure soft tissue 
arthroplasty but is not as good as normal. Recur-
rence of ulnar drift is still a significant problem 
in this type of arthroplasty. 
Another type of arthroplasty which is moving 
us closer to the theoretical optimum of total joint 
replacement is the Steffey; it is a metal prosthesis 
with two sections. Each section has a stem, which 
is inserted into the respective medullary canal, and 
a high density polyethylene articulating surface. The 
two pieces are snap-fitted together and the stems 
are held in place with methylmethacrylate bone 
cement. This prosthesis is a direct outgrowth of the 
earlier metal prosthesis designed by Brannon and 
Fig. 1-Silastic® finger joint prosthesis of the Swanson 
design. 
another designed later by Flatt. One of the most 
important hopes that we have for this prosthesis is 
that it will provide a higher degree of stability. At 
the present time, this particular prosthesis is not 
widely available. 
In closing, I should like to emphasize a point 
that Dr. Bryan has made. It is wise for all of us 
to appreciate the fact that the surgeon always loses 
his battle to rheumatoid arthritis. The best the 
surgeon can possibly hope to do is to ameliorate 
the symptoms or preserve or sometimes even to re-
construct lost functional parts. 
Surgical Care of the Lower Extremity 
in Rheumatoid Arthritis* 
ROBY C. THOMPSON, JR., M. D. 
Professor of Orthopedic Surgery, University of Virginia School of 
Medicine, Charlottesville 
One of the most important things for the phy-
sician to recognize in referring a patient to the 
orthopedic surgeon for treatment of rheumatoid 
arthritis is the goal of surgical correction. The 
primary goal in surgical treatment of diseased joints 
in the lower extremity is relief of pain. Some pain-
free patients have such severe deformities that a 
surgical procedure may be undertaken in order to 
improve and restore function, acceptjng certain cal-
culated risks; however, to improve function sur-
gically in a pain-free joint requires complete and 
full understanding on the part of the patient as well 
as the physician. 
The Hip Joint. The surgical treatment of rheu-
matoid disease in the lower extremity has changed 
drastically in the last t.en years. Mold arthroplasty, 
which was the primary method of treating rheuma-
toid arthritis of the hip joint until ten years ago, 
unfortunately did not provide uniform relief of pain 
and good stability in all patients. In the hands of 
most surgeons doing mold arthroplasties, the rheu-
matoid patient got a less satisfactory result than the 
patient with degenerative arthritis. The major prob-
lem with cup arthroplasty in the patient with rheu-
matoid arthritis was postoperative stiffness and 
residual pain. Figure 1 illustrates the typical com-
plication following this problem, with the cup 
settling into the pelvis and the femoral neck short-
ening under the cup. 
The Austin-Moore prosthesis, which was de-
* Presented by Dr. Thompson at the 45th Annual Mc-
Guire Lecture Series, November 8, 1973, at the Medical 
College of Virginia, Richmond. 
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veloped for the treatment of arthritis in the hip joint, 
subsequently became widely used for the replace-
ment of the femoral head following neck fractures 
in elderly patients. The use of this prosthesis in 
rheumatoid disease of the hip was rarely successful. 
This prosthesis was designed for stability in bone 
on the basis of a press-fit design. It was doomed 
to failure in rheumatoid disease of the hip because 
of inherent osteoporosis, present in most rheuma-
toids, which allowed the unyielding metal of the 
prosthesis to protrude into the soft bone of the 
pelvis and loosen in the soft bone of the femur 
where the stem of the prosthesis frequently became 
loose in the canal of the femur. My personal ex-
perience with femoral head replacement, using the 
Austin-Moore or other press-fit design prostheses 
in rheumatoid arthritis, has been quite disappointing. 
Total hip replacement became popular in Eng-
land about 15 years ago. One of the earliest pros-
theses used was made of two metallic components 
similar in design to the Ring prosthesis illustrated 
in figure 2. Unfortunately, the Ring and other 
types of press-fit design prostheses were doomed to 
failure in rheumatoid arthritis for the same reasons 
that the Austin-Moore prosthesis failed. With our 
patients, in whom the Ring prosthesis was inserted 
for rheumatoid arthritis, we had good early results. 
After a year and a half, however, all but a small 
number of these patients had painful hips. 
Fortunately, polymethylmethacrylate, a bone 
cement, became available for treating arthritic joints. 
This surgical cement, used in this country for over 
five years, is still distributed out of Great Britain. 
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Fig. I-Cup arthroplasty in a rheumatoid hip which failed 
because of shortening of femoral neck and protrusion of 
the cup into the pelvis. 
It has allowed us variability and flexibility for in-
serting all types of total joint replacements utilized 
in the lower extremities today. This cement has many 
advantages in a patient with rheumatoid arthritis. 
In contrast to the press-fit designs, the cement 
backing of a total joint replacement allows a wide 
distribution of forces to the bone, and with few ex-
ceptions, there has been little settling of the ce-
mented prostheses in rheumatoid arthritis. Charnley 
( 1) certainly deserves the credit for establishing 
total hip replacement as a method of choice in treat-
ing diseased hip joints. Credit goes to him, not only 
for the design of the prosthesis which he has popu-
Fig. 2-Ring total hip prosthesis in right hip of rheumatoid 
patient. A press-fit design which failed with time in the 
osteoporotic rheumatoid. 
Fig. 3-The Charnley total hip with a 22 mm femoral 
head of stainless steel and a high density polyethylene 
acetabulum. 
Fig. 4-The Muller total hip with a 32 mm femoral head 
of cobalt chrome alloy and a high density polyethylene 
acetabulum. 
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Fig. SA-Bilateral ankylosed hips in a patient with ankylos-
ing spondylitis. The right hip had previously had a medical 
displacement osteotomy while the left hip had sustained a 
fracture and subsequently ankylosed. 
larized, but also for the fundamental work on bone 
cement. He did original work on the bone cement 
even before he began using total hip replacements 
as we know them today. 
One prosthesis which is very popular in this 
country is the Muller prosthesis ( 2). Materials used 
in this prosthesis are similar to those found in the 
Chamley prosthesis, with a metallic femoral com-
ponent and a high density polyethylene acetabular 
component. Chamley's prosthesis (Fig. 3) is made 
of stainless steel; the Muller prosthesis (Fig. 4) 
is made of a cobalt chrome alloy. 
Fig. SB-Postoperative results following bilateral total hip 
replacements. 
Fig. 6A-Bilateral ankylosed cups in a 20-year-old juvenile 
rheumatoid. 
Rheumatoid arthritis, in a series of hip re-
placements at the University of Virginia, has made 
up a relatively small proportion of those patients 
undergoing total hip replacement. In the first 235 
replaced hips, only 35 hips were replaced for rheu-
matoid arthritis and eight hips for ankylosing spon-
dylitis. In the straightforward rheumatoid arthritic 
patient with destruction of the hip and painful mo-
tion, the results of total hip replacement, using 
cemented prostheses, have been excellent to date. 
We have been pleased with the results in patients on 
whom we performed this procedure and followed 
for three and one-half years without any significant 
Fig. 68-Postoperative conversion to Harris replaceable-
type total hips. Note ectopic bone formation. 
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Fig. ?A-Preoperative condition of patient with ankylosing 
spondylitis, fused spine and ankylosed hips (7B). 
Fig. 7B. 
D.B 10-2-71 
Fig. 7C-Postoperative appearance of hips following bi-
lateral total hip replacements. 
Fig. 7D-Condition of patient postoperatively following 
hip replacements. 
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Fig. 8-Mclntosh plateau prosthesis four years postopera-
tively with good results. 
Fig. 9-Mclntosh prosthesis which failed in rheumatoid 
two years postsurgery. 
failures intrinsic to the rheumatoid process itself. 
In order to show the types of problems that 
are suitable for management with total hip replace-
ment, some of the more unusual cases are presented. 
A 76-year-old lady with ankylosing spondylitis had 
a fused spine, a fused right hip, and an ankylosed 
left hip (Fig. SA). She had little pain but was 
unable to sit or drive a car. With some trepidation, 
we took down her fused hip and used a special type 
of prosthesis where she had previously had a dis-
placement osteotomy. Following a successful result 
on this hip, the left hip was replaced (Fig. SB); 
she is now able to drive a car, sit, and stand. She 
does not have normal movement in her hips but 
has improved markedly in function. 
One of the more difficult problems we face 
is the management of the severe juvenile rheuma-
toid. A 20-year-old boy had bilateral cup arthro-
plasties four years prior to surgery (Fig. 6A ) . Both 
cups were ankylosed and had no motion. We con-
verted his hips to a special type of total hip re-
placement designed by Dr. William Harris of 
Boston (3), using metallic cups which have a re-
placeable polyethylene liner and a metallic femoral 
component. This design concept is used to circum-
vent the problem of wear in the polyetbylene. At 
the present time, all available information suggests 
wear rates of the polyethylene to be a maximum 
of 1 mm every five years, suggesting that with the 
average prosthesis in use today, we can expect a 
minimum of 20 years function, assuming linear 
wear rates are present. This particular patient de-
veloped a complication of ectopic bone formation 
around his hip replacements (Fig. 6B), but he is 
now able to walk, drive a car, and attend college 
regularly, walking without crutches for the first time 
in eight years. In addition, prior to surgery, he was 
unable to sit; he was only able to lie down or stand. 
At the present time, he can sit, stand, and lie down. 
Another difficult case which was dramatically 
improved by" total hip replacements is a S2-year-old 
lady with ankylosing spondylitis, a fused spine, and 
hip joints which were ankylosed in 90 degree flexion. 
She was able to ambulate only with the use of a 
chair for support (Fig. 7 A), and her hip joints were 
markedly protruded (Fig. 7 B). Following bilateral 
total hip replacement, she was able to stand and see 
where she was walking, as well as to sit. She did 
not have a normal gait because of the fused spine 
but was markedly improved (Fig. 7C, D). 
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Fig. IO A, B-Postoperative condition of knee in figure 9, converted to a Walldius hinged prosthesis. 
Fig. 11-Polycentric knee joint as modified from Gunston 
by Bryan and Peterson. 
The Knee Joint. As Dr. McDowell points out, 
synovectomy is a useful procedure if the knee joint 
cartilage itself and the ligaments around the joint 
are not destroyed. When there is rampant synovitis, 
that is, when there is a single joint persistently in-
volved with effusion and synovitis which has failed 
to respond to adequate medical management over 
a period of six months, we feel that synovectomy 
is the treatment of choice. 
In patients with bicompartmental knee disease, 
where both medial and lateral tibial ' plateaus are 
involved as well as femoral condyles, arthroplasty 
is the only successful method of treating the de-
stroyed articular surface. Prior to the advent of 
total knee replacement, tibial plateau and femoral 
condylar prostheses were the only surgical treat-
ments available. In our series of patients, we favored 
the tibial plateau prostheses, designed by Mcintosh, 
and found that some of these replacements did fairly 
well. The patient in figure 8, now four years post-
surgery, is essentially pain free and has an acceptable 
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Fig. 12 A, B-AP and lateral x-ray of knee with destruction secondary to rheumatoid arthritis. 
range of motion and good stability. Many of these 
prostheses did not do well and progressed to un-
stable painful knees. One such patient is a rheuma-
toid arthritic who lost enough bone following her 
Mcintosh arthroplasty to have severe instability and 
pain, requiring major joint reconstruction (Fig. 9). 
We elected to treat this particular problem by 
use of a large hinged prosthesis designed by Wall-
dius ( 4) (Fig. JOA, B). Even though this large 
metallic device has limited motion (90 degrees) 
and carries a certain incidence of looseness and 
infection, it has been in use longer than any other 
knee prosthesis on the market and gives acceptable 
results in the otherwise unsalvageable knee. 
Criteria for Selection of Candidates for Knee 
Replacement. Initially, we restricted our patients 
for knee replacement to those over 60 years of age. 
As we gained experience, we began doing some 
younger patients in the rheumatoid arthritis group 
but have continued to restrict our indications in 
degenerative arthritis to those patients 60 years 
of age and older. 
There are several currently popular prosthetic 
designs available on the market. All of these are 
new and little experience has been recorded with 
any of these joints. My own preference for a knee 
prosthesis is the polycentric knee joint as designed 
by Gunston (5) and modified by Bryan and Peter-
son ( 6) (Fig. 11). I prefer this prosthesis because 
it is embedded in a biologic envelope of bone, has 
minimal bone cement contact, and has less reliance 
on cement-prosthesis contact for stability. In the 
knee joint where there is complete loss of joint space 
and patellofemoral disease (Fig. 12), we have used 
the polycentric arthroplasty, composed of two metal-
lic condyles in the femur and plastic runners in the 
tibia (Fig. 13) with good success. This prosthesis 
basically allows an increase in space between the 
femur and tibia and improves motion as well as 
stability in many knee joints. 
Another popular arthroplasty in the United 
States today is the geometric type (Fig. 14) de-
signed by a group of orthopedic surgeons from four 
different hospitals (7). This two-piece prosthesis 
requires resection of more bone than the polycentric 
arthroplasty, and I have reserved this prosthesis for 
patients with severe osteoporosis and marked joint 
destruction with more than 30 degrees of varus or 
valgus instability. This particular knee joint (Fig. 
15) had such severe osteoporosis, the surgeon's 
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Fig. 13 A, B-AP and lateral x-ray of knee in figure 12 following polycentric arthroplasty. 
Fig. 14-Geometric knee joint. 
thumb could easily be pushed through the femoral 
condyles. A polycentric type of arthroplasty is ex-
tremely difficult to perform in bone as soft as the 
bone in this particular patient, and the geometric 
design has allowed us to replace joints of this type 
providing excellent stability and good motion. The 
average hospital stay for knee replacements at the 
University of Virginia is 26 days for unilateral 
surgery in contrast to an average of 21 days for 
unilateral hip replacement. 
Complications. We have had no cases of phle-
bitis in our total knee replacements, a fact which 
may be due to our prophylactic regimen. We use 
dextran-40 for our total knee replacements, infusing 
200 ml of low molecular weight dextran prior to 
inflation of the tourniquet. The remaining 300 cc 
are infused after the tourniquet is released. The 
patients receive 500 cc of dextran-40 daily for three 
days and then every third day until discharge from 
the hospital. We have had two cases of hepatitis 
in our knee replacements-one patient, presumably 
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Fig. 15 A, B-Pre- and postoperative x-rays of knee with severe osteoporosis where geometric knee joint was used for 
arthroplasty. 
from a transfusion, and the other, anesthesia-related. 
We have had no wound infections to date in our 
knee replacements, which total 35, with a minimum 
of six months follow-up. 
Ankle and Foot. The ankle is a difficult joint to 
treat in rheumatoid arthritis, primarily because it is 
rare to have ankle disease alone without subtalar 
joint disease. Ankle fusion bas been successful in 
several patients I have treated, when the ankle 
has been involved as an isolated joint. The goal of 
surgery in this particular problem must be pain 
relief, as function is rarely improved except as re-
lated to relief of pain. 
One of the more successful surgical procedures 
in the low~f extremity has been the treatment of 
forefoot disease in the rheumatoid patient. In those 
patients with severe hallux valgus and prominent 
metatarsal heads on the plantar surface of the foot, 
resecting the metatarsophalangeal joints has given 
good pain relief in our hands. Again, function can 
only be improved on the basis of pain relief. 
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Diagnostic Concordance of Serological Tests 
for Antiglobulin Antibodies* ** 
MARION WALLER, PH. D. 
Professor of Medicine, Division of Connective Tissue Diseases, 
Medical College of Virginia, Health Sciences Division of Virginia 
Commonwealth University, Richmond 
Rheumatoid factors are present in a variety of 
disease states and in normal persons, usually in low 
titer. High titers of .rheumatoid factors are almost 
exclusively associated with rheumatoid arthritis. 
A second group of antiglobulin antibodies, 
called serum agglutinators, distinct from rheumatoid 
factors, are anti-Fab IgG antibodies presumably 
present in the sera of all mammals. High titers of 
these antibodies are not diagnostic for a specific 
disease but are closely associated with suppurative 
infection which is usually due to gram-positive 
organisms. 
Tests for determining the titers of the serum 
agglutinators are used as diagnostic aids for hidden 
abscesses. In suppurative infection, and especially 
in gram-positive septicemia, titers are very high. 
Elevated titers have aided in differentiating osteo-
myelitic abscesses from des tructive tumor lesions 
of the bone. The titers of the serum agglutinators 
will fall when the suppurative lesions resolve; thus, 
falling titers of these antibodies help in evaluating 
the resolution of large lesions. In addition, the fail-
ure of the patient to respond with a rise in titer 
in the face of significant or multiple abscesses is 
usually a warning that the patient is not immuno-
':' Presented by Dr. Waller at the 45th Annual McGuire 
Lecture Series, November 9, 1973, at the Medical College 
of Virginia, Richmond. 
** This is publication No. 65 from the Charles W. 
Thomas Arthritis Fund, Medical College of Virginia, and 
was supported in part by the Herbert L. Earnest Arthritis 
Fund for research. 
Reprint requests to Dr. Marion Waller, Department of 
Medicine, Medical College of Virginia, Richmond, Vir-
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logically competent, such as patients with thymoma, 
lymphoma or myeloma. Figure 1 demonstrates the 
method used for studying both of these antiglobulin 
antibodies. 
Rh-positive erythrocytes coated with the in-
complete anti-Rh antibody, Ripley, are used to 
demonstrate the rheumatoid factors. These anti-
Rh antibodies, hydrolyzed with various enzymes, 
are used to demonstrate the different serum ag-
glutinators. Erythrocytes coated with a mixture of 
intact antibodies and the Fab fragments of anti-
bodies will permit the demonstration of both anti-
bodies. 
This prospective study of 1,320 persons, whose 
sera were examined for the presence of both rheuma-
toid factors and serum agglutinators, was under-
taken to evaluate and compare the effectiveness of 
the tests for these two distinct antiglobulin anti-
bodies as diagnostic aids in rheumatoid arthritis and 
suppurative infection, respectively. Three groups of 
patients were tested: 
Group I (hospital patients )-Serum specimens 
from 181 hospital patients were sent to our labora-
tory primarily to be tested for the presence of 
serum agglutinators. 
Group 2 (ambulatory patients)-Serum speci-
mens from 926 patients attending the connective 
tissue (rheumatology.) clinics were sent to our 
laboratory to be tested for the presence of rheuma-
toid factors. 
Group 3 ("normal" persons attending the city 
venereal disease clinic)-Serum specimens were 
obtained from 213 persons attending the venereal 
disease clinic. They were primarily young adults, 
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some with and some without complaints of urethral 
or vaginal discharge. Neither antiglobulin test was 
ordered; these were used as a control group. 
For this study, only titers of 160 or above were 
considered as positive tests. Table 1 shows the re-
sults of the tests for rheumatoid factors and serum 
agglutinators in 1,320 patients. The incidence of 
positive tests for serum agglutinators was highest 
in the hospitalized patients (group 1), whereas the 
incidence of positive tests for rheumatoid factors 
was highest, understandably, in the patients attend-
ing the rheumatology clinic (group 2). In the pa-
tients attending the venereal disease clinic (group 
3), the incidence for both types of antiglobulin anti-
bodies was only 1-2%. 
Table 2 shows the variety of diseases among 
the 181 hospital patients. The association between 
positive tests for serum agglutinators and suppura-
tive infection is apparent. In patients with pneu-
monia, suppuration is variable; in addition, there 
is natural drainage, and the patients receive early 
therapy. Thus positive tests are not usual. The 
incidence of positive tests in patients with localized 
infections depends upon the severity of the lesion. 
In neither malignancy nor metabolic disease are 
TABLE 1 
INCIDENCE OF POSITIVE TESTS FOR ANTIGLOBULIN ANTIBODIES* 
Test for Rheumatoid Test for Serum 
Factors Agglutinators 
-------
Study Total No. No. Percent No. Percent 
Group Patients Positive Postive Positive Positive 
181 13 7.1 27 14.9 
2 926 148 16.0 5 0.5 
3 213 3 1.4 4 1.9 
Totals 1,320 164 12.4 36 2.7 
Norn. Group 1 = hospital patients. Group 2 = patients 
attending the rheumatology clinic. Group 3 = patients 
attending the venereal disease clinic. 
* Reprinted by permission from Am J Med 54: 731-734, 
1973. 
TABLE 2 
TESTS FOR SERUM AGGLUTINATORS JN 181 HOSPITAL PATIENTS 
(GROUP 1) WITH A VARIETY OF DISEASES* 
Patients (no.) 
Positive 
Infection Total Test 
Gram-negative septicemia 2 
Pyelonephritis 6 
Pneumonia 11 1 
Granulomatous infection 8 2 
Subacute bacterial endocarditis 3 3 
Large abscesses (empyema, osteomyelitis) 19 12 
Infections associated with immunologic 5 
deficiency (lymphoma, thymoma, 
myeloma, transplantation) 
Localized infection (gonorrhea, 25 4 
pyoderma tonsillitis, infectious 
arthritis , wound infection , decubitus 
ulcers) 
Malignancy 14 
Connective tissue diseases (rheumatoid 19 2 
arthritis, lupus, gout) 
Undiagnosed (fever of undetermined 15 
origin) 
54 Metabolic disease (diabetes, nephrosis, 
toxic drugs, muscular dystrophy, 
alcoholism, cardiovascular disease) 
Totals 181 27 
* Reprinted by permission from Am J Med 54: 731-734, 
1973. 
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these antibodies present in high titer. The exception 
in this instance was a patient with chronic alcoholic 
cirrhosis, hematuria and a hemolytic anemia of 
unknown etiology. Among the patients with con-
nective tissue disease were a two-and-a-half-year-old 
child with lupus erythematosus and a young boy 
with juvenile rheumatoid arthritis; both had high 
titers of serum agglutinators. In neither of these 
diseases are the tests usually positive. It was the 
first hospital admission for both children, however, 
and the possibility that titers may be high in early 
and explosive disease and then decline in the 
chronic state cannot be ruled out. Neither child 
had a positive test for rheumatoid factor or for 
lupus erythematosus. 
Table 3 shows the correlation (or lack of it) 
between the positive test and the disease for which 
the test was ordered. The serum agglutinator test 
was ordered for the hospitalized patients (group 1); 
the rheumatoid factor test was ordered for the 
patients attending the rheumatology clinic (group 
2); and neither test was ordered for the patients 
attending the venereal disease clinic (group 3) . ·In 
13 of the 181 hospitalized patients, the tests for 
rheumatoid factors were positive but only six of 
the 13 had rheumatoid arthritis. Thus, the correla-
tion between positive test and disease state was 
only 46.2%. Among the same patients, however, 
21 of 27 with positive tests for serum agglutinators 
had suppurative infection. 
In the patients attending the rheumatology 
clinic (group 2) , there was a very high correlation 
TABLE 3 
PRESENCE OF RHEUMATOID ARTHRITIS OR SUPPURATIVE 
INFECTION IN PATIENTS WITH POSITIVE TESTS FOR RHEUMATOID 
FACTORS OR SERUM AGGLUTINATORS* 
Rheu- Serum 
matoid Rheu- Agglu- Suppura-
Factor matoid Percent tinator tive Percent 
Study Test Arthritis Correla- Test Infection Correla-
Group Positive Present tion Positive Prese.nt tion 
1 13 6 46 . 2 27 21 77.7 
2 148 145 98.0 5 0 None 
3 3 0 None 4 25 .0 
Totals 164 151 . 92.0 36 23 63.0 
• Reprinted by permission from Am J Med 54: 731-734, 
1973. 
TABLE 4 
FALSE-POSITIVE TESTS FOR ANTIGLOBULIN ANTIBODIES* 
Total 
Study No. 
Group Patients 
181 
2 926 
3 213 
Totals 1,320 
Rheumatoid Factor 
Test 
No. Positive 
Without Percent 
Rheumatoid False-
Arthritis Positive 
7 3.8 
3 0.3 
3 1.4 
13 0.9 
Serum Agglutinator 
Test 
No. Positive 
Without Percent 
Suppurative False-
Infection Positive 
6 3.3 
5 0.5 
3 1.4 
14 1.0 
* Reprinted by permission from Am J Med 54 : 731-734, 
1973. 
between the positive test for rheumatoid factor and 
the presence of rheumatoid arthritis. Of these 926 
patients, five had a positive test for serum agglutina-
tors (0.5 % ) , but norte had a suppurative infection. 
Of the 213 patients attending the venereal 
disease clinic (group 3), three had a positive test 
for rheumatoid factor (1.4 % ) . Only one of these 
three had gonorrhea. None had rheumatoid arthritis. 
Of these 213 patients, four had a positive test for 
serum agglutinators ( 1.9%). Only one had gono-
coccal urethritis. 
If the results of tests for rheumatoid factors 
and serum agglutinators , as standardized in this 
study, are evaluated for correlation of the test with 
specific disease, the percentages of false-positive tests 
among the hospitalized patients (group 1) are 
3.8% and 3.3%, respectively; among the patients 
attending the rheumatology clinic (group 2), 0.3% 
and 0.5%, respectively; and among patients at-
tending the venereal disease clinic (group 3), 1.4% 
and 1.4%, respectively (T:ible 4). These percent-
ages of false-positive tests are much higher when 
titers lower than those used as the standard in this 
study are accepted as positive tests . 
Comments. The requirements for a positive test 
for rheumatoid factors in this study are more strin-
gent than those used in other studies. Even so, only 
46.2% of group 1, with rheumatoid factor titers 
of 160 or above by the sensitized human cell test, 
had rheumatoid arthritis. The sensitized sheep cell 
tests were positive for rheumatoid factor in three 
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of the hospitalized patients in the absence of rheu-
matoid arthritis; the diagnoses in these were 
Wegener's granuloma, chronic heart failure, and 
sarcoidosis. Thus, it is necessary to conclude that 
among very sick patients, positive tests for rheuma-
toid factors only correlate with rheumatoid arthritis 
about 50% of the time. In patients in whom there 
is a high degree of suspicion of the disease, however, 
the correlation is about 98 % . It is also obvious 
that among ambulatory patients attending a clinic 
for a completely unrelated disease, positive tests 
for rheumatoid factors are not apt to correlate with 
rheumatoid arthritis. 
Among the 181 hospitalized patients, 27 
( 15 % ) had elevated titers of serum agglutinators, 
which reflects the interest in infection in this group 
of patients, since the test ordered was for the serum 
agglutinators. Positive tests -for serum agglutinators 
are unusual in nonhospitalized patients and as a rule, 
those who do have positive tests do not have severe 
suppurative infection. In many instances, however, 
these tests might be helpful in differentiating a hid-
den abscess from a malignancy. Sometimes, a well-
walled-off abscess will cause only modest elevations 
in the titers of the serum agglutinators, whereas, 
when the abscess is pierced, its inevitable discharge 
will stimulate the serum agglutinators and the titers 
will rise. As resolution of the lesion occurs, the 
titers will fall. 
This study lends credence to the postulate that 
rheumatoid factors are humoral heterophil anti-
bodies that may be stimulated by a variety of im-
munologic events. As stated, the correlation of posi-
tive tests for these antibodies with rheumatoid 
arthritis is only about 50% in very sick hospitalized 
patients. 
SHll' s Disease in Adults* ** 
WILLIAM M. EDWARDS, M. D. AND STEPHEN R. KOLLER, M. D. 
Fellows in Rheumatology, Division of Connective Tissue Diseases, 
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Commonwealth University, Richmond 
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In 1897, Dr. George F. Still described 22 
children with a form of chronic joint disease which 
differed from rheumatic fever ( 1). Twelve of these 
children had a syndrome characterized by glandular 
and splenic enlargement which, with a characteristic 
fever pattern, rash, and arthritis, has become known 
as Still's disease (2). Subsequent investigators have 
described patients over age 16 presenting with simi-
lar signs and symptoms suggesting that this syn-
drome is not specific for children (3, 4, 5, 6). We 
recently studied a patient in whom the diagnosis of 
adult onset Still's disease was made. 
Case. J . 0 . is a 44-year-old male who was re-
ferred to the Medical College of Virginia Hos-
pitals (MCVH) on May 22, 1973 for evaluation 
of fever of 12 weeks duration. In addition to the 
fever, he had a 25 pound weight loss over a four 
month period, shaking chills, drenching night sweats, 
and progressive weakness and anorexia. Two months 
prior to admission, pain developed in his right knee 
and soon progressed to involve the right great toe, 
both wrists, and fingers of both hands. Aspirin at 
variable doses, prescribed by his private physician, 
* Presented by Drs. Edwards, Koller, and Miller at the 
45th Annual McGuire Lecture Series, November 9, 1973, 
at the Medical College of Virginia, Richmond. 
* * This is publication No. 68 from the Charles W. 
Thomas Arthritis Fund. 
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was not helpful. He had been admitted to another 
hospital on May 7, 1973, where he underwent ex-
tensive laboratory and radiological evaluation, but 
the cause of his symptoms was not ascertained and 
he was transferred to MCVH for furth~r diagnostic 
investigation. 
Past medical history revealed that 12 years 
earlier, he had been seen in another hospital for 
arthritis involving his right wrist which quickly 
resolved. He acknowledged mild morning stiffness 
in his fingers for several years prior to his present 
illness but denied swelling, heat, redness, or de-
creased function in any joint. Adult onset diabetes 
mellitus had been diagnosed one year earlier and 
had been treated with tolbutamide, 500 mg daily. 
Family history was noncontributory. The pa-
tient lives in a rural setting and is employed as a 
maintenance worker in a local seat belt factory. 
He denied the use of cigarettes or alcohol. 
Physical examination on admission revealed 
a T 102°F (39°C), P 92/ min., BP 110/ 58. He 
was in no distress. Pertinent findings included a 
congenital terminal nystagmus on lateral gaze and 
numerous nontender, firm, small, freely movable 
lymph nodes in the anterior cervical region, right 
axilla, left inguinal, and left epitrochlear areas. The 
lungs and heart were normal. The liver measured 
10 cm and was palpable 2 cm below the right costal 
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inargin on deep inspiratiort. The spleen was not 
palpable. The right knee contained a moderate 
effusion but was neither warm nor tender. Both 
wrists were tender and evoked pain on passive 
range of motion. The remainder of the physical 
examination was normal. 
Representative hematological values were: 
hemoglobin 10 gm%, WBC 12,000/ mm3 with 75% 
PMN's, 20% lymphocytes, 5% mononuclear cells, 
and an ESR 66 mm/ hr. (Wintrobe) . Representative 
chemistries included an albumin 3.2 gm% , total 
bilirubin 0.3 mg%, alkaline phosphatase 125 mU / 
ml, lactic dehydrogenase (LDH) 325 mU/ ml 
(LDH-4 and 5 isozymes elevated), and serum 
glutamic oxaloacetic transaminase (SGOT) 70 mU/ 
ml. The following tests were either normal or nega-
tive : urinalysis, blood cultures, latex flocculation, 
antinuclear antibody test (ANA), LE cell prepara-
tions, HBAg (by CEP), heterophil, T,i, T4, sickle 
cell preparation, serologic test for syphilis (STS), 
blood urea nitrogen (BUN) , creatinine, calcium, 
phosphorus, uric acid, amylase, antistreptolysin-0 
(ASO) titer, febrile agglutinins for typhoid, brucella, 
proteus, tularemia, and ioxoplasmosis. Several blood 
sugar determinations were above the normal range, 
the highest being 180 mg%. Intermediate and second 
strength PPD's were negative and a mumps antigen 
elicited 15 mm of induration. Examination of the 
cerebrospinal fluid and bone marrow was not helpful. 
Routine and tuberculosis (Tbc) cultures from 
synovial fluid, urine, sputum, bone marrow, spinal 
fluid, and liver were negative. Upper gastrointestinal 
series (UGI), barium enema, IVP, hand, wrist, and 
chest x-ray studies were normal. Cervical spine films 
showed only mild degenerative arthritis. A liver 
scan was normal. Serum protein electrophoresis 
showed increased a-1 and a-2 globulins only. Analy-
sis of synovial fluid from his right knee revealed 
a WBC 1,144/ mm3 with 30% polymorphonuclear 
leukocytes (PMN's) , 31 % lymphocytes, and 39 % 
mononuclear cells. 
A biopsy of subcutaneous tissue from the pa-
tient's left forearm showed a granulomatous re-
action with moderate vasculitis and lipid-filled 
macrophages. He underwent an exploratory laparo-
tomy with celiac lymph node and liver biopsies. 
Histopathological interpretation of the liver was re-
active hepatitis compatible with a number of sys-
temic diseases and the lymph node showed chronic 
lymphadenitis with lipoid granuloma. A congo red 
stain for amyloid was negative. 
The patient was discharged June 25, 1973 on 
3.6 grams of salicylates per day in divided doses. 
Because of his mild glucose intolerance, it had not 
been felt necessary to supplement his diabetic diet 
with any drug therapy. He was readmitted July 15, 
1973 because of persistent quotidian fever, pain in 
his proximal interphalangeal joints, and morning 
stiffness. In addition, he now complained of pruritus 
over his entire body associated with temperature 
elevations, although no rash was present. He had 
g:;iined five pounds since the first admission. At this 
time he was found to have pain over the medial 
aspect of his right ankle. X-rays of his hands and 
wrists now revealed patchy osteoporosis and cystic 
lucencies involving the radial styloid and proximal 
row of carpal bones (Fig. 1) . He was discharged 
July 25, 1973 on salicylates and Benadryl® with 
a diagnosis of seronegative rheumatoid arthritis. 
Outpatient visits over the next two months 
documented continued quotidian fever (Fig. 2) and 
progressive arthritis, and on September 27, 1973, 
he was readmitted to the hospital. A maculopapular 
rash, lasting hours, mostly on his arms, now ac-
companied the temperature elevations. A synovial 
biopsy of the right knee was performed showing 
nonspecific chronic synovitis (Fig. 3). Serologic 
testing continued to be negative. A diagnosis of adult 
onset Still's disease was made and, in addition to 
salicylates, gold therapy was instituted. 
Over the ensuing months, the patient has felt 
better, has gained 17 pounds, and has experienced 
general improvement of his joint symptoms. The 
general malaise, anorexia, night sweats, chills, and 
persistent quotidian fever have abated. He still, how-
ever, has an occasional temperature elevation with 
an associated fleeting rash. 
Discussion. Despite the increasing sophistica-
tion of the practice of medicine and its effect on 
our diagnostic capabilities, certain patients continue 
to baffle the most astute clinicians with fever of 
undetermined origin (FUO). Many of these patients 
turn out to have neither infectious nor neoplastic 
disorders but, rather, connective tissue diseases, such 
as rheumatoid arthritis (RA), systemic lupus ery-
thematosus (SLE), or even acute rheumatic fever 
(ARF) (7, 8). Still's disease, which is commonly 
included among the causes of FUO's in children, 
has been shown to persist or recur in adulthood 
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Fig. 1-The hand and wrist on the left are normal in May 1973. A subsequent x-ray of the same joints in September 
1973, illustrates the cystic lucencies and osteoporosis. 
(5, 9). In recent years, however, attention has 
focused on a syndrome indistinguishable from child-
hood Still's disease occurring de novo in adults (3, 
4, 5, 6). 
Although there is no pathognomonic finding 
in adult onset Still's disease, certain features may 
be diagnostically useful. A quotidian fever pattern 
is the rule rather than the exception. This quotidian 
pattern may, however, be preceded or succeeded 
by a remittent or even double quotidian pattern. It 
has been pointed out, also, that the fever may be 
present for weeks or for months before arthritis 
develops (2, 5). Often, in association with the 
temperature elevations, a macular or maculopapular 
rash is noted particularly in areas of pressure or 
friction. This migratory, evanescent eruption may 
recur for months in adult onset Still's disease in 
contrast to that of acute rheumatic fever which 
rarely persists longer than two weeks (2, 3, 5). Of 
historical interest concerning the rash of RA and 
juvenile rheumatoid arthritis (JRA), in 1956 Isdale 
and Bywaters (10) reported four adults who de-
veloped a rash in association with other systemic 
manifestations indistinguishable from Still's disease. 
It was not until 1971, however, that these same 
women, along with ten others, were the clinical 
material for Bywaters' original description of adult 
onset Still's disease (3). Many biopsies of the rash 
in adult onset Still's disease have been described, 
yet they all show nonspecific histology, that being 
a mild subepithelial and perivascular polymorpho-
nuclear leukocyte infiltrate (3, 4, 5, 10). 
Lymphadenopathy and splenomegaly corre-
spond significantly with the high fever, rash, and 
leukocytosis in childhood Still's disease ( 11). While 
no mention was made of lymphadenopathy, By-
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waters ( 3) did note splenomegaly in two of his 
patients with adult onset Still's disease, whereas 
six out of ten of those cases reported from the 
National Institutes of Health (NIH) had spleno-
megaly and seven had lymphadenopathy. As in our 
patient, the liver may be involved with an inflam-
matory infiltrate which may recur with relapses of 
the disease and return to normal after recovery ( 5) . 
It has been said that chronic erosive arthritis 
involving cervical spine, sacroiliac, temporomandi-
bular, or peripheral joints may occur in a third or 
more of children with acute onset JRA ( 11, 12, 13). 
Radiographic studies of these areas have not been 
helpful in the adult form of JRA. Although erosive 
arthritis including cervical spine involvement has 
been documented in seven of 26 cases, it is usually 
not severe or widespread (3, 4, 5). On the other 
hand, arthralgias or nonerosive arthritis may be very 
common but transient (3, 4, 5). The histology of 
the synovium may vary in severity from a very mild 
inflammatory reaction as reported by Bywaters (3) 
to a very intense inflammatory response as reported 
by Fabricant et al. ( 4). 
In addition to the more characteristic features 
of adult onset Still's disease, namely fever, rash, 
lymphadenopathy, and arthralgias or nonerosive 
arthritis, one may encounter less specific symptoms. 
Myalgias, particularly of the lumbar, cervical, or 
thigh regions, sore throat, alopecia, pericarditis 
pneumonitis, and pleurisy, with or without a pleural 
effusion, have been described. Abdominal pain may 
occur which possibly reflects mesenteric lymphade-
nitis ( 5). In contrast to JRA, especially the oligo-
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Fig. 2-0ral temperatures recorded by the patient show 
the characteristic quotidian fever pattern of adult onset 
Still's disease. 
Fig. 3-Light microscopy of synovium obtained by needle 
biopsy shows synovial lining cell proliferation and round 
cell infiltration with edema and endothelial proliferation of 
the sublining tissue. 
articular form, iridocyclitis is notably absent in 
adult onset Still's disease. Likewise, rheumatoid 
nodules are not found. 
As in many other connective tissue disorders, 
laboratory confirmation of adult onset Still's disease 
is not possible. Characteristically, rheumatoid factor 
is not found in the sera of these patients. Prob-
ably the most helpful finding is a neutrophilic leuko-
cytosis. Of 12 patients with adult onset Still's dis-
ease, ten had WBC's greater than l 8,000/ mm3 with 
over 70% neutrophils. Similarly, the ESR is ele-
vated and often parallels disease activity (3, 4, 5). 
In only two patients with adult onset Still's disease 
has synovianalysis been reported, one showing a 
white opaque fluid with 69,000 WBC/ mm3 and 
the other, a yellow turbid fluid with 14,000 WBC/ 
mm3• In both aspirates, over 90% of the cells were 
polymorphonuclear leukocytes ( 4) . 
Because of the therapeutic and prognostic im-
plications, physicians should be especially aware 
of a syndrome occurring in an adult, which is in-
distinguishable from Still's disease. Salicylates in 
doses which maintain a serum level of 25-30 mg% 
may induce symptomatic relief in many patients 
with adult onset Still's disease. Others do not re-
spond as favorably and may require additional 
therapy. Of the ten patients with adult onset Still's 
disease comprising the NIH study, four responded 
to high-dose aspirin or indomethacin therapy ( 5) . 
Chloroquine, used in conjunction with aspirin, re-
portedly maintained a normal ESR and good func-
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tional state in one of Bywaters' patients, although 
erosive carpal bones and ankylosis of C 2-3 were 
present (3) . Ultimately, however, the majority of 
patients with adult onset Still's disease have been 
treated with prednisone. Alternate-day therapy is 
preferred if one must resort to steroids; however, 
it has been noted by Bujak et al. (5) that symptoms 
recur on the off day unless the steroids are accom-
panied by very high salicylate doses. Even steroid 
therapy may not fully suppress the activity of adult 
onset Still's disease. One patient who subsequently 
had a remission on gold therapy was reported by 
Fabricant et al. ( 4) to have experienced active 
symptoms despite 30 mg of prednisone daily. The 
only other mention of gold therapy in adult onset 
Still's disease has been by Bywaters in his original 
series, where he commented on two patients who 
improved while taking gold. In one patient, the gold 
therapy was instituted while steroids were being with-
drawn and in the other patient, it was given in 
addition to aspirin and prednisone (3). Thus, our 
patient represents the only report to date of a pa-
tient with adult onset Still's disease responding to 
gold therapy without previous or concomitant cor-
ticosteroid therapy. 
Conclusion. A patient with adult onset Still's 
disease and a review of the literature pertinent to 
this syndrome is presented. Several features should 
be emphasized: 1) Adult onset Still's disease should 
be considered in those patients with FUO who have 
an evanescent rash, leukocytosis, arthritis, or arthral-
gias and Iymphadenopathy. 2) The prognosis of 
adult onset Still's disease is good with few patients, 
so far reported, developing chronic erosive arthritis. 
3) The majority of patients with adult onset Still's 
disease will respond to salicylates, although some 
will require corticosteroids or gold therapy. 
REFERENCES 
I . STILL GF: On a form of chronic joint disease in 
children . Med Clin Trans 80:47, 1897, as reprinted in 
Arch Dis Child 16 :156, 1941. 
2. CALABRO JJ, MARCHESANO JM: The early nat-
ural history of juvenile rheumatoid arthritis . Med Clin 
N orth Am 52:567, 1967 . 
3. BYWATERS EGL: Still's disease in the adult. Ann 
Rheum Dis 30 :121 , 1971. 
4. FABRICANT MS, CHANDOR FB, FRIOU GJ: 
Still's disease in adults : A cause of prolonged un-
diagnosed fever. JAMA 225 :273 , 1973. 
5. BUJAK JS, APTEKAR RG, DECKER JL, WOLFF 
SM: Juvenile rheumatoid arthritis presenting in the 
adult as fever of unknown origin . Medicine 52:431, 
1973. 
6. APTEKAR RG, DECKER JL, BUJAK JF, WOLFF 
SM: Adult onset juvenile rheumatoid disease. A rtli 
Rheum 16:715, 1973 . 
7. PETERSDORF RG, BEESON RB: Fever of un-
explained origin : Report on 100 cases. Medicine 40:1, 
1961. 
8. JACOBY GA, SWARTZ MN: Fever of unde-
termined origin. N Engl J Med 289 : 1407, 1973 . 
9. JEREMY R, SCHALLER J, ARKLESS R, WEDG-
WOOD RJ , HEALEY LA: Juvenile rheumatoid 
arthritis persisting into adulthood. Am J Med 45 :419, 
1968. 
10. ISDALE IC, BYWATERS EGL: The rash of rheu-
matoid arthritis and Still's disease . Q J Med 25:377, 
1956. 
11. CALABRO JJ, MARCHESANO JM: Fever asso-
ciated with juvenile rheumatoid arthritis. N Engl J 
M ed 276:11 , 1967. 
12. CALABRO JJ, MARCHESANO JM: Classification 
of juvenile rheumatoid arthritis. N Engl J Med 277: 
1374, 1967. 
13 . ANSELL BM, BYWATERS EGL: Diagnosis of prob-
able Still's disease and its outcome. Ann Rheum Dis 
21 :253 , 1962. 
Genetic-Metabolic News 
One of the primary aims of the genetic coun-
selor is the reduction in the number of children 
born with either lethal disorders or severe CNS 
dysfunction (eg. mongolism and midline neural de-
fects). Generally, this goal is accomplished in one 
of four major ways: 
1) Where a child's disorder is known to be 
inherited in a Mendelian fashion, by clearly 
stating the recurrence risk of 1 : 2 or 1 : 4, 
which is often a deterrent to a parent pair 
to plan further pregnancies; 
2) By counseling based on empirically estab-
lished recurrence risk statistics; 
3) Where the risk is high, by determining the 
status of the fetus at 14-16 weeks by 
aspiration and study of amniotic fluid (am-
niocentesis,)-when the mother is over 
age 40, or has had a previous child with 
mongolism, a sex-linked disorder, or one of 
so~ fifty metabolic disorders which may 
be diagnosed by amniotic fluid study, the 
pregnancy can be terminated before twenty 
weeks gestation if one of the disorders is 
detected; 
4) By ascertainment of parent pairs where 
both are carriers of an autosomal recessive 
disorder before birth of an involved child 
so that parents may be advised of the high 
risk of occurrence of this disorder in their 
offspring and also be advised of the avail-
ability or nonavailability of intrauterine 
diagnosis by amniocentesis. 
At present, two carrier detection programs (for 
sickle cell anemia and Tay-Sachs disease) have been 
developed because the following necessary criteria 
have been met: 
1) The carrier test is rapid, accurate, and in-
expensive within a defined population; 
2) The frequency of the carrier state is high 
enough within a defined population to justify the 
cost of testing; 
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3) The disorder is a serious health hazard for 
which there is no definitive cure. 
One other disorder, cystic fibrosis (rare in the 
Black race) meets criteria 2 and 3 but unfortunately, 
not 1. As soon as an effective carrier test for this 
disease is developed, however, it will be offered 
to whites just as today, blacks have available sickle 
cell testing and Jews, a Tay-Sachs screening test. 
The major purpose of this article is to briefly 
summarize the concept of a Tay-Sachs carrier de-
tection program and to share our experiences in 
Virginia. This disease, first described by Drs. Tay 
and Sachs in the 1880's, was classified for over 
sixty years as a "degenerative disorder" of the 
central nervous system (CNS). 
Approximately five years ago, however, it was 
shown that the disorder is due to the deficient 
activity of an enzyme, hexosaminidase A, which 
catabolizes a normally occurring ganglioside. The 
accumulation of this sphingolipid causes progressive 
CNS deterioration in an infant who previously de-
veloped normally for the first six-to-nine months 
of life. Death by the age of four or five is inevitable 
since no cure is available or imminent. 
Over the past few years, an accurate procedure 
for the quantitation of hexosaminidase A (hex A) 
activity in serum has been developed whioh identifies 
the carriers of this autosomal recessive disorder. 
Because the Tay-Sachs disease occurs one hundred 
times as frequently in Ashkenazi Jews (those Jews 
of Eastern European and Russian ancestry who 
represent 90% of the United States Jews) as com-
pared to Gentiles and Sephardic Jews, it has become 
feasible and advisable to use this test to screen this 
population for the carrier state. Identification of 
the carrier is important for the following reasons: 
1) It alerts relatives of carriers (through ap-
propriate genetic counseling) of their very 
high- risk for also being a carrier; 
2) It allows identification of couples in the 
childbearing age who may both have the 
abnormal gene and are therefore at a 1 : 4 
43 
44 
risk for having a Tay-Sachs infant. If both 
members of a parent pair are carriers, 
three alternatives exist: 
a) limitation of family size; 
b) therapeutic termination of an involved fetus 
diagnosed by amniocentesis in the 4th 
month of pregnancy; 
c) artificial insemination from a male known 
not to be a Tay-Sachs carrier-this ap-
proach would only be suggested where 
amniocentesis or termination of pregnancy 
are not acceptable to the parents. 
Over the past twenty months, the Departments 
of Pediatrics and Pathology at MCV, in cooperation 
with the Virginia State Health Department and 
concerned local physicians and volunteers, have 
organized intensive educational campaigns to out-
line the rationale of Tay-Sachs carrier testing. These 
efforts in Richmond, Roanoke, Norfolk-Virginia 
Beach, Hampton-Newport News, and Fredericks-
burg, have yielded a voluntary turnout of over 3600 
adult Jews at designated testing dates in community 
centers. 
Complete analysis of over 2000 specimens 
has thus far disclosed a carrier incidence of 1: 30. 
This figure is in close agreement with the 1 : 28 
figure found by the first and largest "outreach" 
Tay-Sachs screening program-that developed by 
Dr. Michael Kaback of the Johns Hopkins Uni-
versity Medical Center for the Baltimore-Wash-
ington area. Approximately a dozen other large 
cities have launched similar programs, but none 
has surpassed the Virginia experience in providing 
this testing to so many people over so large an area. 
Of equal importance to education and testing 
in such a detection program is the availability of 
adequate counseling for the carrier. Professional 
genetic counselors have provided this service for 
every Tay-Sachs carrier in Virginia, including advice 
concerning the importance and method of testing 
at-risk relatives. 
The ultimate national goal of such a carrier 
detection program is to avert the birth of Tay-
Sachs children. This could be done most efficiently 
by testing only married Jewish couples in the 
child-bearing age prior to their planning any chil-
dren. Because lack of funds and the complexity of 
the enzyme measurement presently prohibit the 
wide spread availability of the test, however, this 
is not feasible in most areas of the country. Logic 
dictates, therefore, that the best alternative is first 
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to identify which families (in cities where the test 
is available) carry the gene abnormality and then 
to urge testing for high-risk relatives residing in 
smaller cities where screening is not available. The 
MCV Tay-Sachs Screening Program has received 
frozen serum from as distant a city as Niagara 
Falls, New York, where the relative of a Richmond 
carrier resided. 
For further information regarding the MCV 
Tay-Sachs Screening Program, contact either Dr. 
Peter Mamunes or Dr. Seymour Bakerman by 
writing to Box 187, Medical College of Virginia, 
Richmond 23298, or by telephoning 804-770-3033. 
Sickle cell disease differs from Tay-Sachs dis-
ease in many ways. From the standpoint of carrier 
detection programs, however, the most important 
differences are that: 
1) The test is much simpler and blood speci-
mens can be mailed into a central labor-
atory; 
2) The carrier rate is considerably higher-
approximately 1: 12; 
3) No prenatal test is available when both 
parents are known carriers. 
For these reasons, a greater effort of education and 
testing at an earlier age are indicated. 
Much of the screening for sickle cell trait in 
in the state of Virginia is accomplished by the 
Virginia Sickle Cell Anemia Awareness Program 
(VaSCAP) of the Medical College of Virginia, and 
the sickle cell program of the State Health Depart-
ment. The purposes of these programs are to edu-
cate the public, to provide a screening for young 
people who wish to know whether they carry the 
recessive trait for sickling, and to provide counseling 
for those who have been tested. 
The VaSCAP program at the Medical College 
of Virginia tests young people in the child-bearing 
age, as well as premarital blood samples when 
the test is desired. A total of 11,000 specimens 
per year have been screened, many of them from 
the Richmond metropolitan area. The laboratory 
of the Stat0 Health Department has a capacity for 
up to 40,000 tests a year and collects samples from 
all over the state from individuals of any age. 
The VaSCAP program at MCV also provides 
educational services for the school systems in greater 
Richmond and other outlying areas, as well as edu-
cational programs for organizations and health 
clinics where it is requested. Screening programs 
GENETIC-METABOLIC NEWS 
are provided for public schools and colleges in the 
area, and counseling programs are offered for indi-
viduals tested in the program. In addition, the 
VaSCAP program has provided a series of seminars 
for public health nurses throughout the state to 
teach a larger number of individuals the principles 
of counseling for sickle cell trait. 
The offices of the Virginia Sickle Cell Anemia 
Awareness Program are at 1008 East Clay Street, 
Richmond, Virginia 23298, and the program is 
supervised by Mrs. Florence Cooper. The telephone 
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number is 770-7797. The program of the State 
Health Department is directed by Dr. Patricia Hunt, 
Director, Bureau of Child Health, with offices in 
the Madison Building in Richmond. 
Carrier detection programs, such as those above 
described, have proven that the public will volun-
tarily present themselves for testing if there is ap-
propriate precedent education and follow-up coun-
seling. Every physician should acquaint himself with 
these recently available services and join the effort 
to reduce the incidence of these dreadful disorders. 

A Message to Our Readers: 
The MCV /Q is now in its tenth year of pub-
lication. Since its inception, its quality has shown 
continual improvement and its circulation has quad-
rupled. Despite an increase in advertising revenue, 
however, we are unable to meet the increased costs 
of publication, and we are now faced with severe 
budget restrictions. After this issue, therefore, our 
gratis distribution will be limited to alumni, faculty, 
and students of MCV /VCU, although we hope 
that many of these readers will make voluntary 
contributions or subscribe to the MCV /Q. 
Regretfully, but with an eye to survival, we 
must ask all others who wish to continue to receive 
the MCV /Q, to subscribe at the prices quoted on 
page 7. We hope that you regard this publication 
as well worth the modest cost. To assure that you 
do not miss the next issue, which will present a 
second selection of the papers given at the McGuire 
Lecture Series, and succeeding issues for this year, 
presenting the 27th Annual Stoneburner Lectures 
on "Clinical Advances in Medical and Surgical Neu-
rology," please take a minute to complete the order 
form provided herein and mail it as soon as possible. 
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A service to medical education from A. H. Robins: •·";;(ii. 
Excerpted from Volume 2 ' ~ S;.. 
of theG. I. The A . H . Robins G.I. Series consists of six book- 1. ·. ·-lets. designed to provide a quick, yet com pre hen- [ , 1 
s1ve review o f basic procedures and practices in S G.I. medicine - with particular emphasis on the I erles physical examination as performed in the o ffice or ' ::::.., at bedside. If you have teac hing responsibi lities. """· 
on physical examination 
of the abdomen: 
Normally palpable organs: 
the edge of the liver descending, 
on inspiration, below the costal 
margin (AJ; the lower pole of the 
right kidney (BJ; the abdominal 
aorta (CJ; the descending colon 
and the sigmoid (DJ; the ascend-
ing colon (EJ; and occasionally 
the bladder (though rising of 
this organ beyond the pubis 
does not necessarily indicate 
disease). 
Impossible to outline, unless 
diseased, distended or enlarged 
the gallbladder, pancreas, 
stomach, small intestine, trans-
verse colon and spleen 
limited quantities are available: Part 1 - lnspeclion , 
·-... 
Part 2 - Palpation, Part 3 - Percussion, Part 4 - Auscultation, Part 5 -
Abdomina/ Pain and Part 6 - Differenl!al D iagnosis of Abdominal 
Disorders. Write to : The Medical Department, A. H . Robins Company, 
1407 Cummings Drive. Richmond , Virginia 23220. 
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each tablet. 
capsule or 5 cc . 
teaspoonful 
of elixir 
(23% alcohol) 
hyoscyamine sulfate 0.1037 mg. 
atropine sulfate 0.0194 mg. 
hyoscine hydrobromide 0.0065 mg. 
each 
Don natal 
No. 2 
0.1037mg. 
0.0194 mg. 
0.0065mg. 
phenobarbital (V.. gr.) 16.2 mg. (Y.! gr.) 32.4 mg. 
(warning· may be habit forming) 
each 
Extentab 
o.3111 mg. 
0.0582mg. 
0.0195mg. 
(%gr.) 48.6 mg. 
• Brief sum~ary. Adverse Reactions: Blurring of vision, dry mouth, 
difficult urination, and flushing or dryness of the skin may occur 
on higher dosage levels, rarely on usual dosage. Contraindica-
tions: Glaucoma; renal or hepatic disease;. obstructrve uropathy 
(for example, bladder neck obstructiori due to prostatic hyper-
trophy); or hypersensitivity to any of the ingredients. 
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Before prescribing, please consult 
complete product information, a sum-
mary of which follows: 
Indications: Tension and anxiety 
states, somatic complaints which are 
concomitants of emotional factors; psy-
choneurotic states manifested by tension, 
anxiety, apprehension, fatigue, depres-
sive symptoms or agitation; symptomatic 
relief of acute agitation, tremor, delirium 
tremens and hallucinosis due to acute 
alcohol withdrawal ; adjunctively in skele-
tal muscle spasm due to reflex spasm to 
local pathology, spasticity caused by 
upper motor neuron disorders, athetosis, 
stiff-man syndrome, convulsive disorders 
(not for.sole therapy) . · 
Contraindicated: Known hypersensi-
tivity to the drug. Children under 6 
months of age. Acute narrow angle glau-
coma; may be used in patients with open 
angle glaucoma who are receiving appro-
priate therapy. 
Warnings: Not of value in psychotic 
patients. Caution against hazardous 
occupations requiring complete mental 
alertness. When used adjunctively in con-
vulsive disorders, possibility of increase 
in frequency and/ or severity of grand mal 
seizures may require increased dosage of 
standard anticonvulsant medication; 
abrupt withdrawal may be associated 
with temporary increase in frequency 
and/ or severity of seizures. Advise 
against simultaneous ingestion of alcohol 
and other CNS depressants. Withdrawal 
symptoms (similar to those with barbitu-
rates and alcohol) have occurred follow-
ing abrupt discontinuance (convulsions, 
tremor, abdominal and muscle cramps, 
vomiting and sweating) . Keep addiction-
If there's good reason 
to prescribe 
for psychic tension ... 
prone individuals under careful surveil- : 
lance because of their predisposition to ~r. . 
habituation and dependence. In preg- \;: :J 
nancy, lactation or women of childbearing ;, 
age, weigh potential benefit against 
possible hazard. 
Precautions: If combined with other 
psychotropics or anticonvulsants, con-
sider carefully pharmacology of agents 
employed; drugs such as phenothiazines, 
narcotics, barbiturates, MAO inhibitors 
and other antidepressants may potentiate 
its action. Usual precautions indicated in 
patients severely depressed, or with latent 
depression, or with suicidal tendencies. 
Observe usual precautions in impaired 
renal or hepatic function. Limit dosage to 
smallest effective amount in elderly and 
debilitated to preclude ataxia or over-
sedation. 
Side Effects: Drowsiness, confusion, 
diplopia, hypotension, changes in libido, 
nausea, fatigue, depression, dysarthria, 
jaundice, skin rash, ataxia, constipation, 
headache, incontinence, changes in sali-
vation, slurred speech, tremor, vertigo, 
urinary retention, blurred vision . Para-
doxical reactions such as acute hyper-
excited states, anxiety, hallucinations, 
increased muscle spasticity, insomnia, 
rage, sleep disturbances, stimulation 
have been reported; should these occur, 
discontinue drug. Isolated reports of neu-
tropenia, jaundice; periodic blood counts 
and liver function tests advisable during 
long-term therapy. 
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When, in spite of counseling, 
the patient's pattern of overreaction to stress 
affects his ability to function 
Dependable response 
is a good reason 
to consider Valium 
(diazepam) 
2-mg,5-mg, 
10-mg tablets 
. Division of Hoffmann-La Roche Inc . 
Nutley, N.J. 07110 
